<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:37:45Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9989562" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9989562</identifier>
        <datestamp>2023-03-07</datestamp>
        <setSpec>phenaturepg</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Clin Oral Investig</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin Oral Investig</journal-id>
              <journal-title-group>
                <journal-title>Clinical Oral Investigations</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1432-6981</issn>
              <issn pub-type="epub">1436-3771</issn>
              <publisher>
                <publisher-name>Springer Berlin Heidelberg</publisher-name>
                <publisher-loc>Berlin/Heidelberg</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9989562</article-id>
              <article-id pub-id-type="pmcid">PMC9989562</article-id>
              <article-id pub-id-type="pmc-uid">9989562</article-id>
              <article-id pub-id-type="pmid">36881158</article-id>
              <article-id pub-id-type="pmid">36881158</article-id>
              <article-id pub-id-type="publisher-id">4933</article-id>
              <article-id pub-id-type="doi">10.1007/s00784-023-04933-3</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Comparison of the quality of life changes of patients receiving sagittal split ramus osteotomy or intraoral vertical subsigmoid osteotomy for mandibular prognathism</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wong</surname>
                    <given-names>Natalie Sui Miu</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1"/>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6670-6570</contrib-id>
                  <name>
                    <surname>Leung</surname>
                    <given-names>Yiu Yan</given-names>
                  </name>
                  <address>
                    <email>mikeyyleung@hku.hk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1"/>
                </contrib>
                <aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.194645.b</institution-id><institution-id institution-id-type="ISNI">0000000121742757</institution-id><institution>Oral and Maxillofacial Surgery, Faculty of Dentistry, </institution><institution>The University of Hong Kong, </institution></institution-wrap>34 Hospital Road, Pok Fu Lam, Hong Kong </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>7</day>
                <month>3</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <year>2023</year>
              </pub-date>
              <volume>27</volume>
              <issue>4</issue>
              <fpage>1435</fpage>
              <lpage>1448</lpage>
              <history>
                <date date-type="received">
                  <day>3</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>23</day>
                  <month>2</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</copyright-statement>
                <license>
                  <license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Objective</title>
                  <p id="Par1">To investigate and compare the effect of two orthognathic procedures for mandibular setback, namely, sagittal split ramus osteotomy (SSRO) and intraoral vertical ramus osteotomy (IVRO), on oral health, mental- and physical health-related quality of life across time.</p>
                </sec>
                <sec>
                  <title>Materials and methods</title>
                  <p id="Par2">Patients with mandibular prognathism and planned for orthognathic surgery were recruited in this study. Patients were randomized into two groups (IVRO and SSRO groups). Quality of life (QoL) was assessed with the 14-item Short-Form Oral Health Impact Profile (OHIP-14) and the 36-item Short-Form Health Survey (SF-36) preoperatively (<italic>T</italic><sub>0</sub>), postoperative 2 weeks (<italic>T</italic><sub>1</sub>), 6 weeks (<italic>T</italic><sub>2</sub>), 3 months (<italic>T</italic><sub>3</sub>), 6 months (<italic>T</italic><sub>4</sub>), 12 months (<italic>T</italic><sub>5</sub>), and 24 months (<italic>T</italic><sub>6</sub>). A comparison of OHIP-14 and SF-36 scores between two groups was conducted.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Ninety-eight patients (49 SSRO group, 49 IVRO group) participated in this study. There was no significant difference in OHIP-14 scores between SSRO and IVRO throughout the treatment process. SSRO group had significant reduction of OHIP-14 score (i.e., improving oral health–related QoL) since postoperative 2 weeks, whereas IVRO group had significant reduction since postoperative 6 weeks. Starting from postoperative 3 months, the oral health–related QoL of both groups was already significantly better than the baseline level and continued to steadily improve afterwards. For SF-36, both groups had increased physical health summary score starting from postoperative 2 weeks, indicating an early and gradual recovery of physical health–related QoL. The mental health summary score of the SSRO group began to increase from postoperative 2 weeks, but that of the IVRO group only began to increase from postoperative 6 weeks. Patient age at the time of surgery was positively correlated with OHIP scores in the postoperative period.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">The study concludes that both SSRO and IVRO contributed to the improvement of QoL in the long term, but oral health– and mental health–related QoL of SSRO groups showed earlier improvement.</p>
                </sec>
                <sec>
                  <title>Clinical relevance</title>
                  <p id="Par5">Undergoing orthognathic surgery at early ages is advised, as older age of patients appeared to have worse QoL.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par6">Clinical trial registration number: HKUCTR-1985. Date of Registration: 14 Apr 2015.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Quality of life</kwd>
                <kwd>Orthognathic surgery</kwd>
                <kwd>Dentofacial deformity</kwd>
                <kwd>Intraoral vertical ramus osteotomy</kwd>
                <kwd>Sagittal split ramus osteotomy</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© Springer-Verlag GmbH Germany, part of Springer Nature 2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Introduction</title>
              <p id="Par7">Quality of life (QoL) is a subjective measurement, but essential in providing practitioners insight into patients’ health status related to mental, physical, and social functioning. Changes in perceived health status directly affects treatment satisfaction of patients. When treatment outcome and satisfaction are perceived as personally important in their own life, prolonged life satisfaction will be affected. Thus, this is important to understand the influences of orthognathic surgery on patients’ QoL, so that the gap between expectation of patients and reality can be minimized.</p>
              <p id="Par8">Mandibular prognathism has impacted different aspect of life. In terms of oral functioning, patients with mandibular prognathism would have reduced maximum bite forces and lower masticatory performance, such as difficulty in cutting down foods with central incisors especially if open bite existed [<xref ref-type="bibr" rid="CR1">1</xref>]. They would have issues with speech, such as difficulty in pronouncing the sounds correctly due to altered tongue posture [<xref ref-type="bibr" rid="CR2">2</xref>]. In terms of aesthetics, people with class I profiles were perceived as more visually appealing than those with class II or class III profiles [<xref ref-type="bibr" rid="CR3">3</xref>]. Extensive literature confirmed that individual with attractive appearance would more possibly experience positive evaluation and social interaction than the others [<xref ref-type="bibr" rid="CR4">4</xref>] Consequentially, they could get a job more easily, and receive more favorable treatment from their employer [<xref ref-type="bibr" rid="CR5">5</xref>]. In contrast, people with dentofacial problems were often perceived as less visually appealing and less socially accepted by others, rendering them having lower self-esteem and poorer social responses [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Surgical correction of mandibular prognathism should restore patients’ physical and psychological well-being and improve their oral health–related QoL. Prior studies evaluated the effects of orthognathic surgery on QoL in general [<xref ref-type="bibr" rid="CR8">8</xref>], but did not investigate if the effects were affected by different surgical approaches, with the two commonest techniques being intraoral vertical ramus osteotomy (IVRO) and sagittal split ramus osteotomy (SSRO). The former requires 6-week postoperative intermaxillary fixation (IMF), but presented less short-term and long-term morbidity [<xref ref-type="bibr" rid="CR9">9</xref>] and less surgical relapse [<xref ref-type="bibr" rid="CR10">10</xref>] compared with the latter.</p>
              <p id="Par9">The purpose of the study was to investigate the effects of two types of orthognathic surgery, namely, IVRO and SSRO, on quality of life of patients with mandibular prognathism. To provide a comprehensive assessment of QoL, two instruments OHIP-14 and SF-36 were employed. These instruments were administered before the surgery and at different times during the 24-month follow-up period. We aimed to reveal if there existed group differences in the overall QoL and various domains assessed by the instruments.</p>
            </sec>
            <sec id="Sec2">
              <title>Materials and methods</title>
              <sec id="Sec3">
                <title>Study design</title>
                <p id="Par10">This prospective study is the third part of a larger project investigating the surgical morbidities [<xref ref-type="bibr" rid="CR9">9</xref>] and skeletal movement [<xref ref-type="bibr" rid="CR10">10</xref>] of two orthognathic treatments for mandibular prognathism, SSRO and IVRO. This randomized clinical trial was designed and conducted according to the CONSORT 2010 Statement [<xref ref-type="bibr" rid="CR11">11</xref>]. Ethical approval was granted by the Institutional Review Board (HKU/HA HKW IRB UW 15–132). Written consent was obtained from patients for the use of data analysis.</p>
              </sec>
              <sec id="Sec4">
                <title>Participants</title>
                <p id="Par11">Patients with mandibular prognathism under reviewed for orthognathic surgery in the Discipline of Oral and Maxillofacial Surgery, the Prince Philip Dental Hospital, Hong Kong, were invited to participated into the study. Patients were included if they (1) were aged 18 years or older, (2) had stable skeletal growth as shown by serial lateral and frontal cephalometric radiographs obtained 1 year apart, and (3) had planned for mandibular setback surgical procedure as part or all of the orthognathic surgery. Patients with craniofacial syndromes, any systemic condition predisposing them to infection or contraindicating IMF, a history of previous orthognathic surgery, or pre-existing IAN or LN deficit were excluded.</p>
              </sec>
              <sec id="Sec5">
                <title>Randomization and blinding</title>
                <p id="Par12">This was a double-blind randomized controlled trial. A randomization table was generated from a computer by a house officer who was not participating in the study. The allocation sequence was kept concealed in sealed and opaque envelopes with sequential number by a research nurse officer. The sealed envelope was opened by the surgeon once the study consent was obtained. A simple randomization method was used. Eligible patients who were scheduled for orthognathic surgery including a mandibular setback surgical procedure were randomized into one of the study arms: IVRO group and SSRO group. The chance for each recruited patient randomizing into IVRO group and SSRO group was 50/50.</p>
              </sec>
              <sec id="Sec6">
                <title>Surgical procedures</title>
                <p id="Par13">All procedures were performed under a standardized surgical protocol. Patients were randomized to one of the two study intervention arms: IVRO group or SSRO group. Other orthognathic procedures were performed in a routine manner and sequence if indicated. The surgeries were performed under general anesthesia. The surgical procedures used in the two study arms are described below.</p>
                <p id="Par14">In the IVRO group, a vestibular incision was made at the buccal sulcus. A mucoperiosteal flap was raised to expose the lateral ramus. A sigmoid notch retractor and a posterior border retractor were placed for retraction. A vertical osteotomy from the sigmoid notch to the gonion of the mandible was made with an angled oscillating saw. The osteotomy was completed with a curved osteotome. The occlusion was achieved with an acrylic wager. No internal fixation was applied. IMF was secured with wire and custom-made arch bars for 6 weeks postoperative. The wound was closed with resorbable polyglactin sutures.</p>
                <p id="Par15">In the SSRO group, a standardized SSRO procedure with the Dal Pont-Hunsuck modification was performed. After vestibular incision at the buccal sulcus, a mucoperiosteal flap was raised. A short lingual osteotomy bisecting the upper and lower occlusal plane above the lingula was made. The anterior vertical osteotomy was made on the buccal cortex in the molar region. The lingual and buccal osteotomies were joined along the external oblique ridge. The osteotomies were completed with osteotomes and split to separate the proximal and distal segments. The buccal cortex was trimmed for segment adaptation. The occlusion was established with an acrylic wafer. One titanium miniplate was fixed on each side with four screws. The wounds were closed with resorbable polyglactin sutures. Light guiding elastics were used for 3–4 weeks postoperatively.</p>
                <p id="Par16">For both groups, routine medications including analgesics (paracetamol and codeine phosphate if not allergic), antibiotics (penicillin V if not allergic, for 2 days), and steroids (dexamethasone for 2 days) were given. Standard postoperative instructions were given in the same manner to both groups of patients.</p>
              </sec>
              <sec id="Sec7">
                <title>Outcome measures and time</title>
                <p id="Par17">The primary outcomes of the study were the differences of mean overall score of OHIP-14 and SF-36 between IVRO group and SSRO group before operation (<italic>T</italic><sub>0</sub>), postoperatively 2 weeks (<italic>T</italic><sub>1</sub>), 6 weeks (<italic>T</italic><sub>2</sub>), 3 months (<italic>T</italic><sub>3</sub>), 6 months (<italic>T</italic><sub>4</sub>), 12 months (<italic>T</italic><sub>5</sub>), and 24 months (<italic>T</italic><sub>6</sub>). The secondary outcomes were the differences of mean individual domain score of OHIP-14 and SF-36 between IVRO group and the SSRO group at the baseline and different postoperative time point. The effects of gender and age of patients on OHIP-14 and SF-36 scores were investigated.</p>
              </sec>
              <sec id="Sec8">
                <title>Sample size calculation</title>
                <p id="Par18">This study was reporting the QoL findings of the larger project that compared SSRO and IVRO. The project investigated three major aspects between SSRO and IVRO, namely, surgical morbidities, skeletal stability, and QoL. The sample size calculation was based on the expected difference of one of the major surgical morbidities of the two arms of intervention. Following a previous longitudinal study on inferior alveolar nerve (IAN) deficit after various orthognathic procedures [<xref ref-type="bibr" rid="CR12">12</xref>], the prevalence of an IAN deficit for IVRO and for SSRO was 36.8% and 57.1%, respectively, at postoperative 6 months. With a type 1 error of 5% and power of 80%, 94 sides treated by ramus procedure were required in each group.</p>
              </sec>
              <sec id="Sec9">
                <title>Data collection</title>
                <p id="Par19">The data collection of this study comprised with a package of constructed self-administered questionnaires: (1) oral health status measure, Oral Health Impact Profile (OHIP-14)[<xref ref-type="bibr" rid="CR13">13</xref>]; (2) general health status (physical and psychological) measure, Short-Form Health Survey (SF-36) [<xref ref-type="bibr" rid="CR14">14</xref>]; and (3) demographic information. Demographic information was collected at <italic>T</italic><sub>0</sub>, while OHIP-14 and SF-36 were employed at <italic>T</italic><sub>0</sub>, <italic>T</italic><sub>1</sub>, <italic>T</italic><sub>2</sub>, <italic>T</italic><sub>3</sub>, <italic>T</italic><sub>4</sub>, <italic>T</italic><sub>5</sub>, and <italic>T</italic><sub>6</sub>.</p>
              </sec>
              <sec id="Sec10">
                <title>Instruments</title>
                <sec id="Sec11">
                  <title>Short-Form Oral Health Impact Profile Measure (OHIP-14)</title>
                  <p id="Par20">The OHIP-14 questionnaire was employed to assess the impact oral health condition on well-being. It consists of 14 questions and captures seven domains: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap. Each domain comprises of 2 questions. Patients were asked to rate the frequency of the situation occurred as described with a 5-point Likert scale: 0 = never, 1 = hardly ever, 2 = occasionally, 3 = fairly often, and 4 = very often. The overall OHIP-14 score ranges from 0 to 56, and each of the individual domain score ranges from 0 to 8. A higher score indicates poor QoL. The Chinese version of OHIP-14 was adopted in this study, which was proved to be valid and reliable [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
                </sec>
                <sec id="Sec12">
                  <title>36-Items Short-Form Health Survey (SF-36)</title>
                  <p id="Par21">Psychological and physical well-being were assessed using 36-Items Short Form Survey (SF-36) [<xref ref-type="bibr" rid="CR14">14</xref>]. The validated Chinese (Hong Kong) version of SF-36 was employed in this study [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. It consists of eight domains, namely, physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH). These eight domains derive two summary scores, mental health summary (MCS) and physical health summary (PCS), which indicate the perception of individual mental health and physical health status. The score of MCS, PCS, and each domain ranges from 0 to 100, with a higher score indicating better health status.</p>
                </sec>
              </sec>
              <sec id="Sec13">
                <title>Statistical analysis</title>
                <p id="Par22">Data were analyzed using IBM SPSS Statistics version 26.0 (IBM Corp., Armonk, NY, USA). The 5% probability was taken as the cut-off for statistical significance. Descriptive statistics were performed to describe the mean score of QoL (i.e., OHIP-14 and SF-36 scores) at different time intervals (<italic>T</italic><sub>0</sub> to <italic>T</italic><sub>6</sub>). Independent sample <italic>t</italic>-test was utilized to compare the QoL in various time intervals between IVRO and SSRO groups. Correlation was performed to investigate the relationship of QoL with age and gender. Effect size was calculated by computing the mean group difference, and then divided it by the pooled standard deviation (SD).</p>
              </sec>
            </sec>
            <sec id="Sec14">
              <title>Results</title>
              <p id="Par23">A total of 98 patients (40 males and 58 females, 41% male) with mandibular prognathism planned for orthognathic surgery participated in the study. Patients were randomized into IVRO group (50%) and SSRO group (50%). The demographic information of patients between IVRO group and SSRO group at baseline is shown in Table <xref rid="Tab1" ref-type="table">1</xref>. The mean age of 98 patients was 24.5 years (SD = 3.5, range = 18–33). The mean age was 24.5 in both the IVRO group and SSRO, with SD of 3.6 and 3.5, respectively (<italic>p</italic> &gt; 0.05). Among the 98 patients, 91% (89/98) were assessed in <italic>T</italic><sub>1</sub>, 91% (89/98) were assessed in <italic>T</italic><sub>2</sub>, 94% (92/98) were assessed in <italic>T</italic><sub>3</sub>, 92% (90/98) were assessed in <italic>T</italic><sub>4</sub>, 91% (89/98) were assessed in <italic>T</italic><sub>5</sub>, and 81% (79/98) were assessed in <italic>T</italic><sub>6</sub>. The reasons of loss to follow-up included loss of contact with the hospital, study abroad, and COVID-19 pandemic.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Descriptive characteristics of the participants at baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="2">Total<break/>(<italic>n</italic> = 98)</th><th align="left" colspan="2">IVRO group<break/>(<italic>n</italic> = 49)</th><th align="left" colspan="2">SSRO group<break/>(<italic>n</italic> = 49)</th><th align="left" rowspan="2"><italic>p</italic> value</th></tr><tr><th align="left"/><th align="left"><italic>n</italic></th><th align="left">%</th><th align="left"><italic>n</italic></th><th align="left">%</th><th align="left"><italic>n</italic></th><th align="left">%</th></tr></thead><tbody><tr><td align="left" colspan="8">Gender</td></tr><tr><td align="left">  Male</td><td align="left">40</td><td align="left">40.8</td><td align="left">15</td><td char="." align="char">30.6</td><td align="left">25</td><td char="." align="char">51.0</td><td char="." align="char">0.040</td></tr><tr><td align="left">  Female</td><td align="left">58</td><td align="left">59.2</td><td align="left">34</td><td char="." align="char">69.4</td><td align="left">24</td><td char="." align="char">19.0</td><td char="." align="char"/></tr><tr><td align="left" colspan="8">Age</td></tr><tr><td align="left">  Mean (SD)</td><td align="left" colspan="2">24.5 (3.5)</td><td align="left" colspan="2">24.5 (3.5)</td><td align="left" colspan="2">24.5 (3.5)</td><td char="." align="char">0.920</td></tr><tr><td align="left">  Range</td><td align="left" colspan="2">18–33</td><td align="left" colspan="2">18–32</td><td align="left" colspan="2">18–33</td><td char="." align="char"/></tr></tbody></table></table-wrap></p>
              <sec id="Sec15">
                <title>Longitudinal change of oral health–related QoL in IVRO group and SSRO group (OHIP-14)</title>
                <p id="Par24">The mean (SD) OHIP-14 total scores among 96 patients were 16.3 (8.5) at <italic>T</italic><sub>0</sub>, 23.0 (10.9) at <italic>T</italic><sub>1</sub>, 19.4 (9.9) at <italic>T</italic><sub>2</sub>, 11.8 (8.6) at <italic>T</italic><sub>3</sub>, 9.2 (7.1) at <italic>T</italic><sub>4</sub>, 7.8 (7.5) at <italic>T</italic><sub>5</sub>, and 5.4 (6.2) at <italic>T</italic><sub>6</sub> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The pattern of change in OHIP-14 total scores among IVRO and SSRO group were identical, and no significant difference of the OHIP-14 total scores between two groups were observed for each time point. There was a significant increase in OHIP-14 total score (i.e., worsen oral health–related QoL) from <italic>T</italic><sub>0</sub> to <italic>T</italic><sub>1</sub> for patients in both IVRO (<italic>p</italic> = 0.003) and SSRO groups (<italic>p</italic> &lt; 0.001). Starting from <italic>T</italic><sub>1</sub>, a significant decrease of OHIP-14 total scores for both groups was found (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), representing a significant improvement of oral health–related QoL was observed at <italic>T</italic><sub>1</sub> onwards. The oral health–related QoL of both groups started to become better than pre-treatment at <italic>T</italic><sub>3</sub> and continue to improve steadily in the late postoperative period until <italic>T</italic><sub>6</sub>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Change of OHIP-14 mean total score over time between IVRO group and SSRO group</p></caption><graphic xlink:href="784_2023_4933_Fig1_HTML" id="MO1"/></fig></p>
              </sec>
              <sec id="Sec16">
                <title>Group difference in the change of perceived oral health–related QoL (OHIP-14)</title>
                <p id="Par25">Throughout the treatment process, no significant difference of the OHIP-14 total scores and domain scores between two groups were observed in any time point. During the early postoperative period from <italic>T</italic><sub>1</sub> to <italic>T</italic><sub>2</sub>, however, the decrease in magnitude of OHIP-14 total score was significantly larger in SSRO group than IVRO group (<italic>p</italic> = 0.007) (Table <xref rid="Tab2" ref-type="table">2</xref>). It indicated the oral health–related quality of life significantly improved more in SSRO group than IVRO group. When the domain scores were examined, it was found that the more superior improvement in the SSRO group could be attributed to social disability and handicap scores (Table <xref rid="Tab2" ref-type="table">2</xref>). From <italic>T</italic><sub>3</sub> onwards (i.e., late postoperative period), both groups improved steadily (Table <xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Comparisons of mean (SD) and changes of OHIP-14 total and domain scores between IVRO group and SSRO group over time (<italic>T</italic><sub>0</sub> to <italic>T</italic><sub>6</sub>)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left"/><td align="left">Baseline (T<sub>0</sub>)</td><td align="left">Postoperative 2 weeks (T<sub>1</sub>)</td><td align="left" colspan="3">T<sub>0</sub> toT<sub>1</sub></td><td align="left">Postoperative 6 weeks (T<sub>2</sub>)</td><td align="left" colspan="3">T<sub>1</sub> to T<sub>2</sub></td><td align="left">Postoperative 3 months (T<sub>3</sub>)</td><td align="left" colspan="3">T<sub>2</sub> to T<sub>3</sub></td></tr><tr><td align="left"/><td align="left">Mean (SD)</td><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic>-value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic>-value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic>-value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td></tr><tr><td align="left" colspan="14">OHIP-14 total score [0–56]</td></tr><tr><td align="left"> IVRO</td><td align="left">16.9 (8.2)</td><td align="left">21.7 (10.7)</td><td align="left">4.5 (9.7)</td><td align="left">0.022</td><td align="left">-0.500</td><td align="left">20.4 (11.4)</td><td align="left">-1.2 (8.6)</td><td align="left">0.007</td><td align="left">0.602</td><td align="left">11.5 (8.8)</td><td align="left">-9.4 (10.0)</td><td align="left">0.117</td><td align="left">-0.343</td></tr><tr><td align="left"> SSRO</td><td align="left">15.7 (8.9)</td><td align="left">25.2 (12.9)</td><td align="left">9.5 (10.5)</td><td align="left"/><td align="left"/><td align="left">18.4 (8.1)</td><td align="left">-6.4 (8.9)</td><td align="left"/><td align="left"/><td align="left">12.1 (8.5)</td><td align="left">-6.4 (7.0)</td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Functional limitation [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">4.1 (2.0)</td><td align="left">5.2 (2.2)</td><td align="left">1.2 (2.3)</td><td align="left">0.096</td><td align="left">-0.361</td><td align="left">4.5 (2.3)</td><td align="left">-0.7 (2.4)</td><td align="left">0.196</td><td align="left">0.285</td><td align="left">2.7 (1.7)</td><td align="left">-1.9 (2.2)</td><td align="left">0.330</td><td align="left">-0.213</td></tr><tr><td align="left"> SSRO</td><td align="left">4.0 (2.1)</td><td align="left">5.8 (1.9)</td><td align="left">2.0 (2.3)</td><td align="left"/><td align="left"/><td align="left">4.7 (1.7)</td><td align="left">-1.3 (1.8)</td><td align="left"/><td align="left"/><td align="left">3.2 (1.7)</td><td align="left">-1.5 (1.5)</td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Physical pain [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">2.7 (1.3)</td><td align="left">3.4 (1.9)</td><td align="left">0.1 (1.8)</td><td align="left">0.008</td><td align="left">-0.575</td><td align="left">3.1 (1.8)</td><td align="left">-0.3 (1.7)</td><td align="left">0.153</td><td align="left">0.312</td><td align="left">1.9 (1.7)</td><td align="left">-1.2 (1.7)</td><td align="left">0.328</td><td align="left">-0.213</td></tr><tr><td align="left"> SSRO</td><td align="left">2.3 (1.7)</td><td align="left">4.2 (2.1)</td><td align="left">1.9 (2.3)</td><td align="left"/><td align="left"/><td align="left">3.4 (1.4)</td><td align="left">-0.9 (2.0)</td><td align="left"/><td align="left"/><td align="left">2.6 (1.7)</td><td align="left">-0.9 (1.6)</td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Psychological discomfort [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">2.9 (1.6)</td><td align="left">3.0 (1.6)</td><td align="left">0.1 (1.5)</td><td align="left">0.096</td><td align="left">0.360</td><td align="left">2.9 (1.9)</td><td align="left">-0.1 (1.6)</td><td align="left">0.130</td><td align="left">0.330</td><td align="left">1.4 (1.5)</td><td align="left">-1.5 (1.9)</td><td align="left">0.245</td><td align="left">-0.255</td></tr><tr><td align="left"> SSRO</td><td align="left">2.7 (1.8)</td><td align="left">3.3 (1.9)</td><td align="left">0.7 (1.9)</td><td align="left"/><td align="left"/><td align="left">2.5 (1.5)</td><td align="left">-0.7 (2.0)</td><td align="left"/><td align="left"/><td align="left">1.5 (1.6)</td><td align="left">-1.1 (1.4)</td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Physical disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">2.1 (1.7)</td><td align="left">3.0 (2.2)</td><td align="left">0.8 (1.9)</td><td align="left">0.507</td><td align="left">-0.143</td><td align="left">3.1 (2.1)</td><td align="left">0.0 (1.9)</td><td align="left">0.314</td><td align="left">0.220</td><td align="left">1.9 (1.6)</td><td align="left">-1.1 (2.1)</td><td align="left">0.174</td><td align="left">-0.298</td></tr><tr><td align="left"> SSRO</td><td align="left">1.8 (1.6)</td><td align="left">2.7 (1.9)</td><td align="left">1.1 (2.2)</td><td align="left"/><td align="left"/><td align="left">2.3 (1.6)</td><td align="left">-0.4 (1.9)</td><td align="left"/><td align="left"/><td align="left">1.7 (1.5)</td><td align="left">-0.6 (1.5)</td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Psychological disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">3.1 (1.7)</td><td align="left">2.8 (1.8)</td><td align="left">-0.3 (1.7)</td><td align="left">0.092</td><td align="left">-0.366</td><td align="left">2.6 (1.9)</td><td align="left">-0.2 (1.4)</td><td align="left">0.201</td><td align="left">0.283</td><td align="left">1.9 (1.7)</td><td align="left">-0.8 (1.5)</td><td align="left">0.770</td><td align="left">-0.064</td></tr><tr><td align="left"> SSRO</td><td align="left">2.8 (1.8)</td><td align="left">3.1 (2.1)</td><td align="left">0.4 (1.8)</td><td align="left"/><td align="left"/><td align="left">2.4 (1.5)</td><td align="left">-0.6 (1.9)</td><td align="left"/><td align="left"/><td align="left">1.7 (1.7)</td><td align="left">-0.7 (1.6)</td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Social disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">1.3 (1.6)</td><td align="left">2.3 (2.0)</td><td align="left">0.9 (2.4)</td><td align="left">0.065</td><td align="left">-0.403</td><td align="left">2.3 (2.2)</td><td align="left">0.0 (1.7)</td><td align="left">0.001</td><td align="left">0.742</td><td align="left">0.9 (1.3)</td><td align="left">-1.5 (2.2)</td><td align="left">0.079</td><td align="left">-0.383</td></tr><tr><td align="left"> SSRO</td><td align="left">1.2 (1.4)</td><td align="left">3.0 (2.3)</td><td align="left">1.8 (2.2)</td><td align="left"/><td align="left"/><td align="left">1.6 (1.5)</td><td align="left">-1.3 (1.8)</td><td align="left"/><td align="left"/><td align="left">0.8 (1.4)</td><td align="left">-0.8 (1.5)</td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Handicap [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">0.7 (1.1)</td><td align="left">1.9 (1.9)</td><td align="left">1.0 (2.0)</td><td align="left">0.227</td><td align="left">-0.260</td><td align="left">2.0 (2.0)</td><td align="left">0.1 (1.9)</td><td align="left">0.005</td><td align="left">0.625</td><td align="left">0.8 (1.3)</td><td align="left">-1.3 (2.0)</td><td align="left">0.280</td><td align="left">-0.234</td></tr><tr><td align="left"> SSRO</td><td align="left">0.9 (1.2)</td><td align="left">2.5 (2.2)</td><td align="left">1.6 (2.4)</td><td align="left"/><td align="left"/><td align="left">1.4 (1.5)</td><td align="left">-1.1 (1.9)</td><td align="left"/><td align="left"/><td align="left">0.6 (1.3)</td><td align="left">-0.9 (1.8)</td><td align="left"/><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left">Postoperative 6 months (T<sub>4</sub>)</td><td align="left" colspan="3">T<sub>3</sub> to T<sub>4</sub></td><td align="left">Postoperative 12 months (T<sub>5</sub>)</td><td align="left" colspan="3">T4 to T5</td><td align="left">Postoperative 24 months (T<sub>6</sub>)</td><td align="left" colspan="3">T<sub>5</sub> to T<sub>6</sub></td></tr><tr><td align="left"/><td align="left"/><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic>- value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic>- value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic>- value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td></tr><tr><td align="left" colspan="14">OHIP-14 total score [0–56]</td></tr><tr><td align="left"> IVRO</td><td align="left">9.0 (7.3)</td><td align="left">-2.3 (4.3)</td><td align="left">0.165</td><td align="left">0.297</td><td align="left">7.6 (6.9)</td><td align="left">-1.6 (4.8)</td><td align="left">0.648</td><td align="left">-0.100</td><td align="left">5.9 (6.6)</td><td align="left">-2.0 (4.7)</td><td align="left">0.251</td><td align="left">0.268</td><td align="left"/></tr><tr><td align="left"> SSRO</td><td align="left">9.3 (7.0)</td><td align="left">-3.9 (6.4)</td><td align="left"/><td align="left"/><td align="left">8.0 (8.1)</td><td align="left">-1.1 (6.7)</td><td align="left"/><td align="left"/><td align="left">4.9 (5.8)</td><td align="left">-3.2 (4.8)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Functional limitation [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">2.0 (1.6)</td><td align="left">-0.6 (1.0)</td><td align="left">0.054</td><td align="left">0.417</td><td align="left">1.6 (1.4)</td><td align="left">-0.5 (0.9)</td><td align="left">0.857</td><td align="left">0.041</td><td align="left">1.3 (1.5)</td><td align="left">-0.3 (1.1)</td><td align="left">0.176</td><td align="left">0.315</td><td align="left"/></tr><tr><td align="left"> SSRO</td><td align="left">2.3 (1.6)</td><td align="left">-1.1 (1.4)</td><td align="left"/><td align="left"/><td align="left">1.8 (1.6)</td><td align="left">-0.5 (1.4)</td><td align="left"/><td align="left"/><td align="left">1.1 (1.3)</td><td align="left">-0.7 (1.2)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Physical pain [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">1.5 (1.6)</td><td align="left">-0.3 (1.6)</td><td align="left">0.117</td><td align="left">0.340</td><td align="left">1.2 (1.3)</td><td align="left">-0.4 (1.5)</td><td align="left">0.444</td><td align="left">-0.169</td><td align="left">1.2 (1.7)</td><td align="left">-0.2 (1.5)</td><td align="left">0.087</td><td align="left">0.403</td><td align="left"/></tr><tr><td align="left"> SSRO</td><td align="left">1.9 (1.4)</td><td align="left">-0.9 (1.7)</td><td align="left"/><td align="left"/><td align="left">1.7 (1.7)</td><td align="left">-0.1 (1.8)</td><td align="left"/><td align="left"/><td align="left">1.1 (1.3)</td><td align="left">-0.7 (1.2)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Psychological discomfort [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">1.1 (1.4)</td><td align="left">-0.3 (1.0)</td><td align="left">0.338</td><td align="left">0.209</td><td align="left">1.2 (1.3)</td><td align="left">0.1 (0.9)</td><td align="left">0.623</td><td align="left">0.112</td><td align="left">0.9 (1.3)</td><td align="left">-0.3 (1.2)</td><td align="left">0.655</td><td align="left">0.105</td><td align="left"/></tr><tr><td align="left"> SSRO</td><td align="left">1.1 (1.2)</td><td align="left">-0.5 (1.2)</td><td align="left"/><td align="left"/><td align="left">1.0 (1.4)</td><td align="left">-0.1 (1.6)</td><td align="left"/><td align="left"/><td align="left">0.6 (1.0)</td><td align="left">-0.4 (0.9)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Physical disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">1.6 (1.3)</td><td align="left">-0.3 (1.2)</td><td align="left">0.900</td><td align="left">0.027</td><td align="left">1.3 (1.4)</td><td align="left">-0.3 (1.3)</td><td align="left">0.645</td><td align="left">-0.102</td><td align="left">1.0 (1.3)</td><td align="left">-0.4 (1.2)</td><td align="left">0.609</td><td align="left">0.119</td><td align="left"/></tr><tr><td align="left">  SSRO</td><td align="left">1.6 (1.4)</td><td align="left">-0.3 (1.6)</td><td align="left"/><td align="left"/><td align="left">1.3 (1.4)</td><td align="left">-0.2 (1.4)</td><td align="left"/><td align="left"/><td align="left">0.8 (0.9)</td><td align="left">-0.6 (1.3)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Psychological disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">1.6 (1.5)</td><td align="left">-0.2 (1.1)</td><td align="left">0.432</td><td align="left">0.168</td><td align="left">1.4 (1.5)</td><td align="left">-0.3 (1.2)</td><td align="left">0.945</td><td align="left">0.015</td><td align="left">1.0 (1.2)</td><td align="left">-0.5 (1.0)</td><td align="left">0.258</td><td align="left">-0.264</td><td align="left"/></tr><tr><td align="left">  SSRO</td><td align="left">1.4 (1.4)</td><td align="left">-0.5 (1.5)</td><td align="left"/><td align="left"/><td align="left">1.1 (1.4)</td><td align="left">-0.3 (1.4)</td><td align="left"/><td align="left"/><td align="left">0.8 (1.3)</td><td align="left">-0.2 (1.0)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Social disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">0.6 (0.9)</td><td align="left">-0.3 (0.9)</td><td align="left">0.664</td><td align="left">0.093</td><td align="left">0.4 (0.9)</td><td align="left">-0.1 (0.7)</td><td align="left">0.214</td><td align="left">-0.277</td><td align="left">0.3 (0.6)</td><td align="left">-0.1 (0.7)</td><td align="left">0.436</td><td align="left">0.181</td><td align="left"/></tr><tr><td align="left"> SSRO</td><td align="left">0.5 (0.9)</td><td align="left">-0.4 (1.0)</td><td align="left"/><td align="left"/><td align="left">0.5 (1.0)</td><td align="left">0.1 (0.7</td><td align="left"/><td align="left"/><td align="left">0.3 (0.6)</td><td align="left">-0.2 (0.7)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="14">Handicap [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">0.5 (1.0)</td><td align="left">-0.2 (0.9)</td><td align="left">0.917</td><td align="left">-0.022</td><td align="left">0.4 (0.8)</td><td align="left">-0.1 (0.8)</td><td align="left">0.346</td><td align="left">-0.208</td><td align="left">0.3 (0.6)</td><td align="left">-0.1 (0.7)</td><td align="left">0.146</td><td align="left">0.339</td><td align="left"/></tr><tr><td align="left"> SSRO</td><td align="left">0.5 (0.9)</td><td align="left">-0.2 (1.1)</td><td align="left"/><td align="left"/><td align="left">0.5 (1.1)</td><td align="left">0.1 (1.0)</td><td align="left"/><td align="left"/><td align="left">0.3 (0.6)</td><td align="left">-0.4 (0.8)</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p><sup>a</sup> “ + ” value = score increased (i.e., decreased in oral health–related QoL); “-” value = score decreased (i.e., increased in oral health–related QoL)</p><p><sup>b</sup><italic>p</italic> value were calculated from independent sample <italic>t</italic>-test between IVRO group and SSRO group</p><p><sup>c</sup>Effect size: &lt; 0.2 = minimal change; 0.2–0.49 = small change; 0.5–0.8 = moderate change; &gt; 0.8 = large change</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Comparisons of mean (SD) OHIP-14 total and domain scores of IVRO group and SSRO group from baseline (<italic>T</italic><sub>0</sub>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="2"><italic>T</italic><sub>1</sub>-<italic>T</italic><sub>0</sub></th><th align="left" colspan="2"><italic>T</italic><sub>2</sub><italic>-T</italic><sub>0</sub></th><th align="left" colspan="2"><italic>T</italic><sub>3</sub><italic>-T</italic><sub>0</sub></th><th align="left" colspan="2"><italic>T</italic><sub>4</sub><italic>-T</italic><sub>0</sub></th><th align="left" colspan="2"><italic>T</italic><sub>5</sub><italic>-T</italic><sub>0</sub></th><th align="left" colspan="2"><italic>T</italic><sub>6</sub><italic>-T</italic><sub><italic>0</italic></sub></th></tr><tr><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th></tr></thead><tbody><tr><td align="left" colspan="13">OHIP-14 total score [0–56]</td></tr><tr><td align="left">  IVRO</td><td align="left">4.5 (9.7)</td><td align="left">0.003</td><td align="left">3.5 (11.1)</td><td align="left">0.041</td><td align="left"> − 6.1 (9.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 8.1 (8.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 9.5 (9.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 10.4 (9.0)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left">  SSRO</td><td align="left">9.5 (10.5)</td><td align="left"> &lt; 0.001</td><td align="left">2.7 (7.7)</td><td align="left">0.028</td><td align="left"> − 3.1 (6.4)</td><td align="left">0.003</td><td align="left"> − 7.1 (7.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 8.0 (8.2)</td><td align="left"> &lt; 0.001</td><td align="left"> − 11.0 (7.1)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> All</td><td align="left">6.9 (10.3)</td><td align="left"> &lt; 0.001</td><td align="left">3.1 (9.5)</td><td align="left">0.003</td><td align="left"> − 4.6 (7.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 7.7 (7.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 8.8 (9.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 10.7 (8.7)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left" colspan="13">Functional limitation [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">1.2 (2.3)</td><td align="left">0.001</td><td align="left">0.5 (2.3)</td><td align="left">0.206</td><td align="left"> − 1.6 (1.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.1 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.5 (1.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.6 (2.0)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> SSRO</td><td align="left">2.0 (2.3)</td><td align="left"> &lt; 0.001</td><td align="left">0.7 (2.1)</td><td align="left">0.033</td><td align="left"> − 0.8 (2.0)</td><td align="left">0.014</td><td align="left"> − 1.9 (1.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.3 (1.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 3.0 (1.9)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> All</td><td align="left">1.6 (2.3)</td><td align="left"> &lt; 0.001</td><td align="left">0.6 (2.2)</td><td align="left">0.017</td><td align="left"> − 1.2 (2.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.0 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.4 (1.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.8 (2.0)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left" colspan="13">Physical pain [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">0.1 (1.8)</td><td align="left">0.009</td><td align="left">0.5 (1.8)</td><td align="left">0.108</td><td align="left"> − 0.5 (1.8)</td><td align="left">0.004</td><td align="left"> − 1.2 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.5 (1.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.3 (1.8)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> SSRO</td><td align="left">1.9 (2.3)</td><td align="left"> &lt; 0.001</td><td align="left">1.0 (1.7)</td><td align="left">0.001</td><td align="left">0.3 (1.6)</td><td align="left">0.245</td><td align="left"> − 0.6 (1.8)</td><td align="left">0.039</td><td align="left"> − 0.6 (1.8)</td><td align="left">0.037</td><td align="left"> − 1.3 (1.8)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> All</td><td align="left">1.3 (2.1)</td><td align="left"> &lt; 0.001</td><td align="left">0.7 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 0.3 (1.8)</td><td align="left">0.169</td><td align="left"> − 0.9 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.0 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.3 (1.8)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left" colspan="13">Psychological discomfort [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">0.1 (1.5)</td><td align="left">0.775</td><td align="left">0.0 (2.0)</td><td align="left">0.941</td><td align="left"> − 1.6 (1.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.9 (1.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.8 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.0 (1.8)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> SSRO</td><td align="left">0.7 (1.9)</td><td align="left">0.025</td><td align="left"> − 0.2 (1.7)</td><td align="left">0.544</td><td align="left"> − 1.1 (1.6)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.6 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.8 (1.6)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.2 (1.5)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> All</td><td align="left">0.4 (1.7)</td><td align="left">0.057</td><td align="left"> − 0.1 (1.9)</td><td align="left">0.650</td><td align="left"> − 1.4 (1.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.7 (1.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.8 (1.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.1 (1.7)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left" colspan="13">Physical disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">0.8 (1.9)</td><td align="left">0.006</td><td align="left">0.9 (1.8)</td><td align="left">0.003</td><td align="left"> − 0.3 (1.8)</td><td align="left">0.254</td><td align="left"> − 0.6 (1.7)</td><td align="left">0.021</td><td align="left"> − 0.7 (1.9)</td><td align="left">0.013</td><td align="left"> − 1.1 (2.1)</td><td align="left">0.002</td></tr><tr><td align="left"> SSRO</td><td align="left">1.1 (2.2)</td><td align="left">0.002</td><td align="left">0.6 (1.7)</td><td align="left">0.034</td><td align="left">0.1 (1.3)</td><td align="left">0.722</td><td align="left"> − 0.3 (1.6)</td><td align="left">0.262</td><td align="left"> − 0.4 (1.7)</td><td align="left">0.107</td><td align="left"> − 0.9 (1.2)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> All</td><td align="left">1.0 (2.1)</td><td align="left"> &lt; 0.001</td><td align="left">0.7 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 0.1 (1.6)</td><td align="left">0.458</td><td align="left"> − 0.4 (1.6)</td><td align="left">0.013</td><td align="left"> − 0.6 (1.8)</td><td align="left">0.003</td><td align="left"> − 1.0 (1.7)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left" colspan="13">Psychological disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">-0.3 (1.7)</td><td align="left">0.278</td><td align="left"> − 0.4 (2.3)</td><td align="left">0.237</td><td align="left"> − 1.3 (1.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.4 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.7 (2.1)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.9 (1.9)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> SSRO</td><td align="left">0.4 (1.8)</td><td align="left">0.200</td><td align="left"> − 0.5 (1.9)</td><td align="left">0.105</td><td align="left"> − 1.0 (1.5)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.5 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.8 (1.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.1 (1.7)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left"> All</td><td align="left">0.0 (1.8)</td><td align="left">0.905</td><td align="left"> − 0.4 (2.1)</td><td align="left">0.049</td><td align="left"> − 1.2 (1.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.5 (1.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.8 (1.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.0 (1.8)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left" colspan="13">Social disability [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">0.9 (2.4)</td><td align="left">0.012</td><td align="left">1.0 (2.5)</td><td align="left">0.010</td><td align="left"> − 0.4 (1.7)</td><td align="left">0.100</td><td align="left"> − 0.7 (1.5)</td><td align="left">0.001</td><td align="left"> − 0.9 (1.7)</td><td align="left">0.001</td><td align="left"> − 1.0 (1.8)</td><td align="left">0.001</td></tr><tr><td align="left"> SSRO</td><td align="left">1.8 (2.2)</td><td align="left"> &lt; 0.001</td><td align="left">0.5 (1.4)</td><td align="left">0.026</td><td align="left"> − 0.3 (1.4)</td><td align="left">0.194</td><td align="left"> − 0.8 (1.3)</td><td align="left"> &lt; 0.001</td><td align="left"> − 0.7 (1.5)</td><td align="left">0.002</td><td align="left"> − 1.0 (1.4)</td><td align="left">0.000</td></tr><tr><td align="left"> All</td><td align="left">1.3 (2.3)</td><td align="left"> &lt; 0.001</td><td align="left">0.7 (2.0)</td><td align="left">0.001</td><td align="left"> − 0.3 (1.5)</td><td align="left">0.035</td><td align="left"> − 0.8 (1.4)</td><td align="left"> &lt; 0.001</td><td align="left"> − 0.8 (1.6)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.0 (1.6)</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left" colspan="13">Handicap [0–8]</td></tr><tr><td align="left"> IVRO</td><td align="left">1.0 (2.0)</td><td align="left">0.001</td><td align="left">1.2 (2.1)</td><td align="left"> &lt; 0.001</td><td align="left">0.0 (1.3)</td><td align="left">0.908</td><td align="left"> − 0.2 (1.3)</td><td align="left">0.231</td><td align="left"> − 0.4 (1.3)</td><td align="left">0.077</td><td align="left"> − 0.5 (1.3)</td><td align="left">0.025</td></tr><tr><td align="left"> SSRO</td><td align="left">1.6 (2.4)</td><td align="left"> &lt; 0.001</td><td align="left">0.6 (1.6)</td><td align="left">0.014</td><td align="left"> − 0.3 (1.3)</td><td align="left">0.151</td><td align="left"> − 0.5 (1.2)</td><td align="left">0.012</td><td align="left"> − 0.3 (1.5)</td><td align="left">0.133</td><td align="left"> − 0.6 (1.1)</td><td align="left">0.004</td></tr><tr><td align="left"> All</td><td align="left">1.3 (2.2)</td><td align="left"> &lt; 0.001</td><td align="left">0.9 (1.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 0.1 (1.3)</td><td align="left">0.336</td><td align="left"> − 0.4 (1.3)</td><td align="left">0.010</td><td align="left"> − 0.4 (1.4)</td><td align="left">0.020</td><td align="left"> − 0.5 (1.2)</td><td align="left"> &lt; 0.001</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> + ”value = score increased (i.e., decreased in oral health–related QoL); “-” value = score decreased (i.e., increased in oral health–related QoL)</p><p><sup>b</sup><italic>p</italic> value were computed from paired sample <italic>t</italic>-test</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec17">
                <title>Longitudinal change of psychological and physical health–related QoL in IVRO group and SSRO group (SF-36)</title>
                <p id="Par26">The mean total score of physical health score (PCS) and mental health score (MCS) among 96 patients were presented in Table <xref rid="Tab4" ref-type="table">4</xref>. The pattern of change in PCS total scores among IVRO and SSRO group were identical, no significant difference of the PCS total score between two groups were observed. PCS significantly dropped (i.e., worsened physical health-related QoL) from <italic>T</italic><sub>0</sub> to <italic>T</italic><sub>1</sub> in both groups (<italic>p</italic> &lt; 0.001). Subsequently, a significant increase in PCS total scores (i.e., improvement in physical-related QoL) were observed in both group from <italic>T</italic><sub>1</sub> to <italic>T</italic><sub>2</sub> (<italic>p</italic> &lt; 0.001), and from <italic>T</italic><sub>2</sub> to <italic>T</italic><sub>3</sub> (<italic>p</italic> &lt; 0.001). From <italic>T</italic><sub>3</sub> onwards, PCS scores in both groups became stable (<italic>p</italic> &gt; 0.05) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Meanwhile, MCS dropped significantly (i.e., worsened in mental health–related QoL) from <italic>T</italic><sub>0</sub> to <italic>T</italic><sub>1</sub> in both groups (<italic>p</italic> &lt; 0.05). For SSRO group, there was a significant increase in MCS (i.e., improvement in mental health-related QoL) from <italic>T</italic><sub>1</sub> to <italic>T</italic><sub>2</sub>, and <italic>T</italic><sub>2</sub> to <italic>T</italic><sub>3</sub> (<italic>p</italic> &lt; 0.001). However, MCS in IVRO group continuously decreased from <italic>T</italic><sub>1</sub> to <italic>T</italic><sub>2</sub> (<italic>p</italic> = 0.023), and only started to significantly increase from <italic>T</italic><sub>2</sub> to <italic>T</italic><sub>3</sub> (<italic>p</italic> &lt; 0.001). MCS from <italic>T</italic><sub>3</sub> onwards were relatively stable (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). PCS and MCS in both groups returned to baseline level in <italic>T</italic><sub>6</sub> (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Comparisons of mean (SD) and changes of SF-36 total physical health score (PCS), mental health score (MCS), and domain scores between IVRO group and SSRO group over time (<italic>T</italic><sub>0</sub> to <italic>T</italic><sub>6</sub>)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left"/><td align="left"><p>Baseline</p><p>(T<sub>0</sub>)</p></td><td align="left"><p>Postoperative</p><p>2 weeks (T<sub>1</sub>)</p></td><td align="left" colspan="3">T<sub>0</sub> toT<sub>1</sub></td><td align="left"><p>Postoperative 6 weeks</p><p>(T<sub>2</sub>)</p></td><td align="left" colspan="3">T<sub>1</sub> to T<sub>2</sub></td><td align="left"><p>Postoperative 3 months</p><p>(T<sub>3</sub>)</p></td><td align="left" colspan="3">T<sub>2</sub> to T<sub>3</sub></td></tr><tr><td align="left"/><td align="left">Mean (SD)</td><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic> value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic> value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td><td align="left">Mean (SD)</td><td align="left">Mean<sup>a</sup> (SD)</td><td align="left"><italic>p</italic> value<sup>b</sup></td><td align="left">Effect size<sup>c</sup></td></tr><tr><td align="left" colspan="14">Physical health score (PCS)</td></tr><tr><td align="left" colspan="14">[0–100]</td></tr><tr><td align="left"> IVRO</td><td align="left">55.4 (5.7)</td><td align="left">40.2 (11.5)</td><td align="left"> − 15.7 (10.9)</td><td align="left">0.776</td><td align="left">0.062</td><td align="left">46.5 (8.0)</td><td align="left">6.2 (8.7)</td><td align="left">0.032</td><td align="left">-0.475</td><td align="left">54.2 (6.8)</td><td align="left">8.0 (8.0)</td><td align="left">0.078</td><td char="." align="char">0.385</td></tr><tr><td align="left"> SSRO</td><td align="left">55.3 (5.2)</td><td align="left">38.8 (9.6)</td><td align="left"> − 16.3 (8.9)</td><td align="left"/><td align="left"/><td align="left">48.2 (7.0)</td><td align="left">10.0 (7.0)</td><td align="left"/><td align="left"/><td align="left">53.5 (6.3)</td><td align="left">5.4 (5.3)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Mental health score (MCS)</td></tr><tr><td align="left" colspan="14">[0–100]</td></tr><tr><td align="left"> IVRO</td><td align="left">51.8 (6.8)</td><td align="left">47.9 (8.9)</td><td align="left"> − 3.7 (9.5)</td><td align="left">0.081</td><td align="left">0.380</td><td align="left">45.0 (9.7)</td><td align="left">-3.0 (8.5)</td><td align="left">0.011</td><td align="left">-0.564</td><td align="left">52.5 (8.7)</td><td align="left">7.0 (10.7)</td><td align="left">0.174</td><td char="." align="char">0.295</td></tr><tr><td align="left"> SSRO</td><td align="left">54.2 (6.7)</td><td align="left">47.1 (11.1)</td><td align="left"> − 7.5 (10.8)</td><td align="left"/><td align="left"/><td align="left">49.6 (11.0)</td><td align="left">2.4 (10.6)</td><td align="left"/><td align="left"/><td align="left">53.2 (8.9)</td><td align="left">4.0 (9.1)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Physical functioning (PF)</td></tr><tr><td align="left"> IVRO</td><td align="left">97.6 (5.4)</td><td align="left">79.8 (18.0)</td><td align="left"> − 17.9 (18.5)</td><td align="left">0.527</td><td align="left">0.137</td><td align="left">87.6 (12.5)</td><td align="left">7.6 (15.8)</td><td align="left">0.050</td><td align="left">-0.430</td><td align="left">96.7 (6.1)</td><td align="left">9.5 (12.4)</td><td align="left">0.022</td><td char="." align="char">0.508</td></tr><tr><td align="left"> SSRO</td><td align="left">98.6 (3.5)</td><td align="left">78.2 (15.3)</td><td align="left"> − 20.2 (14.9)</td><td align="left"/><td align="left"/><td align="left">91.8 (7.8)</td><td align="left">13.8 (13.0)</td><td align="left"/><td align="left"/><td align="left">95.5 (6.2)</td><td align="left">4.5 (6.3)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Role-physical (RP)</td></tr><tr><td align="left"> IVRO</td><td align="left">93.2 (18.4)</td><td align="left">35.6 (39.3)</td><td align="left"> − 57.6 (40.4)</td><td align="left">0.368</td><td align="left">0.194</td><td align="left">41.1 (39.6)</td><td align="left">3.9 (40.6)</td><td align="left">0.003</td><td align="left">-0.660</td><td align="left">86.4 (28.2)</td><td align="left">47.1 (39.8)</td><td align="left">0.062</td><td char="." align="char">0.407</td></tr><tr><td align="left"> SSRO</td><td align="left">92.2 (17.2)</td><td align="left">28.6 (36.4)</td><td align="left"> − 65.2 (37.9)</td><td align="left"/><td align="left"/><td align="left">55.6 (44.2)</td><td align="left">29.3 (36.2)</td><td align="left"/><td align="left"/><td align="left">87.5 (29.2)</td><td align="left">30.8 (40.0)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Bodily pain (BP)</td></tr><tr><td align="left"> IVRO</td><td align="left">88.3 (14.3)</td><td align="left">60.1 (23.2)</td><td align="left"> − 27.9 (23.4)</td><td align="left">0.313</td><td align="left">0.218</td><td align="left">73.6 (20.8)</td><td align="left">13.7 (22.6)</td><td align="left">0.372</td><td align="left">-0.194</td><td align="left">87.2 (16.1)</td><td align="left">13.2 (20.3)</td><td align="left">0.646</td><td char="." align="char">0.099</td></tr><tr><td align="left"> SSRO</td><td align="left">88.2 (18.1)</td><td align="left">55.1 (18.9)</td><td align="left"> − 32.9 (22.7)</td><td align="left"/><td align="left"/><td align="left">71.3 (16.4)</td><td align="left">17.8 (20.2)</td><td align="left"/><td align="left"/><td align="left">83.0 (16.0)</td><td align="left">11.3 (16.0)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">General health (GH)</td></tr><tr><td align="left"> IVRO</td><td align="left">71.5 (16.5)</td><td align="left">66.6 (17.8)</td><td align="left"> − 5.9 (14.6)</td><td align="left">0.500</td><td align="left"> − 0.146</td><td align="left">67.5 (15.8)</td><td align="left">2.0 (12.9)</td><td align="left">0.644</td><td align="left">-0.101</td><td align="left">71.8 (17.2)</td><td align="left">3.4 (14.8)</td><td align="left">0.841</td><td char="." align="char">0.043</td></tr><tr><td align="left"> SSRO</td><td align="left">72.0 (16.1)</td><td align="left">67.6 (18.6)</td><td align="left"> − 3.8 (14.9)</td><td align="left"/><td align="left"/><td align="left">71.1 (16.1)</td><td align="left">3.1 (8.8)</td><td align="left"/><td align="left"/><td align="left">73.0 (18.5)</td><td align="left">2.9 (7.7)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Vitality (VT)</td></tr><tr><td align="left"> IVRO</td><td align="left">67.8 (12.9)</td><td align="left">57.3 (15.7)</td><td align="left"> − 9.1 (17.3)</td><td align="left">0.128</td><td align="left">0.328</td><td align="left">62.8 (15.5)</td><td align="left">5.7 (11.9)</td><td align="left">0.030</td><td align="left">-0.473</td><td align="left">69.3 (15.9)</td><td align="left">6.3 (16.7)</td><td align="left">0.274</td><td char="." align="char">0.237</td></tr><tr><td align="left"> SSRO</td><td align="left">73.1 (14.8)</td><td align="left">58.6 (20.0)</td><td align="left"> − 15.1 (19.1)</td><td align="left"/><td align="left"/><td align="left">69.7 (18.7)</td><td align="left">12.1 (15.0)</td><td align="left"/><td align="left"/><td align="left">72.0 (16.5)</td><td align="left">2.7 (13.5)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Social functioning (SF)</td></tr><tr><td align="left"> IVRO</td><td align="left">89.1 (12.8)</td><td align="left">60.1 (24.0)</td><td align="left"> − 28.9 (26.1)</td><td align="left">0.113</td><td align="left">0.346</td><td align="left">58.9 (21.1)</td><td align="left">-1.7 (27.8)</td><td align="left">0.025</td><td align="left">-0.496</td><td align="left">86.7 (16.3)</td><td align="left">27.6 (22.4)</td><td align="left">0.061</td><td char="." align="char">0.409</td></tr><tr><td align="left"> SSRO</td><td align="left">94.3 (9.6)</td><td align="left">56.8 (23.8)</td><td align="left"> − 37.8 (25.4)</td><td align="left"/><td align="left"/><td align="left">69.4 (21.9)</td><td align="left">11.9 (16.9)</td><td align="left"/><td align="left"/><td align="left">88.0 (16.0)</td><td align="left">18.9 (20.1)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Role-emotional (RE)</td></tr><tr><td align="left"> IVRO</td><td align="left">88.9 (24.1)</td><td align="left">78.7 (32.2)</td><td align="left"> − 8.7 (35.4)</td><td align="left">0.194</td><td align="left">0.283</td><td align="left">70.4 (39.7)</td><td align="left">-8.1 (32.7)</td><td align="left">0.047</td><td align="left">-0.433</td><td align="left">89.1 (27.3)</td><td align="left">17.1 (37.4)</td><td align="left">0.169</td><td char="." align="char">0.299</td></tr><tr><td align="left"> SSRO</td><td align="left">92.4 (23.1)</td><td align="left">73.8 (39.3)</td><td align="left"> − 20.3 (45.9)</td><td align="left"/><td align="left"/><td align="left">82.2 (33.0)</td><td align="left">7.3 (38.4)</td><td align="left"/><td align="left"/><td align="left">87.0 (25.8)</td><td align="left">7.0 (29.6)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Mental health (MH)</td></tr><tr><td align="left"> IVRO</td><td align="left">75.7 (13.1)</td><td align="left">76.2 (11.9)</td><td align="left">0.9 (15.1)</td><td align="left">0.433</td><td align="left">0.169</td><td align="left">74.9 (11.4)</td><td align="left">-1.1 (11.1)</td><td align="left">0.138</td><td align="left">-0.321</td><td align="left">78.9 (13.2)</td><td align="left">3.0 (14.1)</td><td align="left">0.519</td><td char="." align="char">0.139</td></tr><tr><td align="left"> SSRO</td><td align="left">77.4 (10.6)</td><td align="left">76.1 (14.5)</td><td align="left"> − 1.6 (13.5)</td><td align="left"/><td align="left"/><td align="left">78.3 (15.5)</td><td align="left">2.9 (13.6)</td><td align="left"/><td align="left"/><td align="left">78.6 (15.5)</td><td align="left">1.2 (11.1)</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" rowspan="3" colspan="2"/><td align="left" rowspan="2">Postoperative 6 months (T<sub>4</sub>)</td><td align="left" colspan="3">T<sub>3</sub> to T<sub>4</sub></td><td align="left" rowspan="2">Postoperative 12 months (T<sub>5</sub>)</td><td align="left" colspan="3">T<sub>4</sub> to T<sub>5</sub></td><td align="left" rowspan="2">Postoperative 24 months (T<sub>6</sub>)</td><td align="left" colspan="3">T<sub>5</sub> to T<sub>6</sub></td></tr><tr><td align="left" rowspan="2">Mean<sup>a</sup> (SD)</td><td align="left" rowspan="2"><italic>p</italic> value<sup>b</sup></td><td align="left" rowspan="2">Effect size<sup>c</sup></td><td align="left" rowspan="2">Mean<sup>a</sup> (SD)</td><td align="left" rowspan="2"><italic>p</italic> value<sup>b</sup></td><td align="left" rowspan="2">Effect size<sup>c</sup></td><td align="left" rowspan="2">Mean<sup>a</sup> (SD)</td><td align="left" rowspan="2"><italic>p</italic> value<sup>b</sup></td><td align="left" rowspan="2">Effect size<sup>c</sup></td></tr><tr><td align="left">Mean (SD)</td><td align="left">Mean (SD)</td><td align="left">Mean (SD)</td></tr><tr><td align="left" colspan="14">Physical health score (PCS) [0–100]</td></tr><tr><td align="left"> IVRO</td><td align="left">54.0 (8.4)</td><td align="left"> − 0.4 (7.3)</td><td align="left">0.292</td><td align="left"> − 0.231</td><td align="left">55.2 (6.0)</td><td align="left">1.0 (7.0)</td><td align="left">0.876</td><td align="left"> − 0.035</td><td align="left">55.7 (5.3)</td><td align="left">0.3 (3.3)</td><td align="left">0.356</td><td align="left"> − 0.216</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">54.2 (6.4)</td><td align="left">1.0 (4.4)</td><td align="left"/><td align="left"/><td align="left">55.5 (4.9)</td><td align="left">1.2 (4.2)</td><td align="left"/><td align="left"/><td align="left">56.7 (3.6)</td><td align="left">0.9 (3.1)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Mental health score (MCS) [0–100]</td></tr><tr><td align="left"> IVRO</td><td align="left">53.7 (6.4)</td><td align="left">1.4 (8.1)</td><td align="left">0.498</td><td align="left">0.145</td><td align="left">52.1 (10.1)</td><td align="left"> − 1.3 (9.5)</td><td align="left">0.380</td><td align="left"> − 0.197</td><td align="left">54.1 (6.7)</td><td align="left">2.1 (8.6)</td><td align="left">0.126</td><td align="left">0.361</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">52.8 (9.2)</td><td align="left">0.1 (9.3)</td><td align="left"/><td align="left"/><td align="left">53.8 (7.5)</td><td align="left">0.04 (7.6)</td><td align="left"/><td align="left"/><td align="left">53.0 (7.6)</td><td align="left"> − 0.7 (6.6)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Physical functioning (PF)</td></tr><tr><td align="left"> IVRO</td><td align="left">95.0 (13.9)</td><td align="left"> − 2.0 (12.8)</td><td align="left">0.173</td><td align="left"> − 0.301</td><td align="left">98.3 (3.8)</td><td align="left">3.4 (13.3)</td><td align="left">0.573</td><td align="left">0.128</td><td align="left">98.0 (4.1)</td><td align="left"> − 0.5 (4.4)</td><td align="left">0.130</td><td align="left"> − 0.359</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">96.7 (7.0)</td><td align="left">1.0 (5.0)</td><td align="left"/><td align="left"/><td align="left">98.9 (2.8)</td><td align="left">2.1 (5.4)</td><td align="left"/><td align="left"/><td align="left">99.9 (0.8)</td><td align="left">0.7 (1.8)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Role-physical (RP)</td></tr><tr><td align="left"> IVRO</td><td align="left">92.2 (21.4)</td><td align="left">5.0 (29.0)</td><td align="left">0.937</td><td align="left">0.017</td><td align="left">92.2 (19.8)</td><td align="left">0.6 (14.8)</td><td align="left">0.980</td><td align="left"> − 0.005</td><td align="left">95.8 (14.5)</td><td align="left">1.3 (19.0)</td><td align="left">0.825</td><td align="left"> − 0.051</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">93.5 (20.0)</td><td align="left">5.5 (28.2)</td><td align="left"/><td align="left"/><td align="left">93.7 (20.3)</td><td align="left">0.7 (16.9)</td><td align="left"/><td align="left"/><td align="left">96.6 (12.0)</td><td align="left">2.1 (11.0)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Bodily pain (BP)</td></tr><tr><td align="left"> IVRO</td><td align="left">88.5 (19.7)</td><td align="left">0.8 (18.9)</td><td align="left">0.707</td><td align="left"> − 0.081</td><td align="left">86.3 (17.5)</td><td align="left"> − 2.5 (13.0)</td><td align="left">0.060</td><td align="left"> − 0.417</td><td align="left">90.8 (14.5)</td><td align="left">3.6 (10.6)</td><td align="left">0.127</td><td align="left">0.354</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">84.5 (19.7)</td><td align="left">2.2 (15.2)</td><td align="left"/><td align="left"/><td align="left">88.6 (15.3)</td><td align="left">4.0 (17.7)</td><td align="left"/><td align="left"/><td align="left">88.1 (13.7)</td><td align="left"> − 0.6 (13.2)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">General health (GH)</td></tr><tr><td align="left"> IVRO</td><td align="left">71.2 (17.1)</td><td align="left"> − 0.6 (11.9)</td><td align="left">0.813</td><td align="left"> − 0.051</td><td align="left">72.4 (19.9)</td><td align="left">0.3 (13.6)</td><td align="left">0.855</td><td align="left">0.040</td><td align="left">73.3 (18.2)</td><td align="left">1.6 (14.0)</td><td align="left">0.714</td><td align="left"> − 0.084</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">70.7 (18.2)</td><td align="left">0.0 (9.8)</td><td align="left"/><td align="left"/><td align="left">71.3 (18.0)</td><td align="left"> − 0.2 (12.4)</td><td align="left"/><td align="left"/><td align="left">74.6 (14.6)</td><td align="left">2.6 (9.0)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left"> All</td><td align="left">71.0 (17.5)</td><td align="left"> − 0.3 (10.9)</td><td align="left"/><td align="left"/><td align="left">71.8 (18.9)</td><td align="left">0.1 (13.0)</td><td align="left"/><td align="left"/><td align="left">73.9 (16.5)</td><td align="left">2.1 (11.8)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Vitality (VT)</td></tr><tr><td align="left"> IVRO</td><td align="left">70.2 (14.5)</td><td align="left">1.2 (13.5)</td><td align="left">0.563</td><td align="left">0.124</td><td align="left">67.6 (19.0)</td><td align="left"> − 2.7 (14.2)</td><td align="left">0.202</td><td align="left"> − 0.285</td><td align="left">69.9 (16.9)</td><td align="left">2.5 (15.0)</td><td align="left">0.420</td><td align="left">0.189</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">70.2 (14.9)</td><td align="left"> − 0.5 (13.5)</td><td align="left"/><td align="left"/><td align="left">72.2 (14.4)</td><td align="left">1.2 (13.1)</td><td align="left"/><td align="left"/><td align="left">72.0 (13.2)</td><td align="left"> − 0.1 (12.8)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Social functioning (SF)</td></tr><tr><td align="left"> IVRO</td><td align="left">91.1 (11.8)</td><td align="left">4.3 (16.5)</td><td align="left">0.337</td><td align="left">0.208</td><td align="left">90.3 (17.7)</td><td align="left"> − 0.6 (12.9)</td><td align="left">0.323</td><td align="left"> − 0.218</td><td align="left">93.7 (10.4)</td><td align="left">3.5 (13.4)</td><td align="left">0.645</td><td align="left">0.107</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">89.0 (16.1)</td><td align="left">1.2 (13.3)</td><td align="left"/><td align="left"/><td align="left">92.3 (14.1)</td><td align="left">2.6 (16.2)</td><td align="left"/><td align="left"/><td align="left">94.6 (9.1)</td><td align="left">2.1 (13.5)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Role-emotional (RE)</td></tr><tr><td align="left">  IVRO</td><td align="left">93.1 (16.8)</td><td align="left">3.6 (29.2)</td><td align="left">0.945</td><td align="left"> − 0.014</td><td align="left">88.9 (24.6)</td><td align="left"> − 2.3 (22.0)</td><td align="left">0.536</td><td align="left"> − 0.137</td><td align="left">96.0 (18.3)</td><td align="left">6.8 (27.8)</td><td align="left">0.098</td><td align="left">0.384</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">91.3 (26.1)</td><td align="left">4.1 (30.9)</td><td align="left"/><td align="left"/><td align="left">92.4 (21.4)</td><td align="left">0.9 (23.9)</td><td align="left"/><td align="left"/><td align="left">91.9 (22.8)</td><td align="left"> − 1.9 (15.8)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="14">Mental health (MH)</td></tr><tr><td align="left"> IVRO</td><td align="left">76.7 (11.7)</td><td align="left"> − 1.6 (11.3)</td><td align="left">0.850</td><td align="left"> − 0.040</td><td align="left">76.4 (14.5)</td><td align="left"> − 0.2 (13.0)</td><td align="left">0.759</td><td align="left"> − 0.068</td><td align="left">78.5 (14.6)</td><td align="left">1.4 (13.4)</td><td align="left">0.160</td><td align="left">0.331</td><td char="." align="char"/></tr><tr><td align="left"> SSRO</td><td align="left">76.0 (13.3)</td><td align="left"> − 1.1 (12.9)</td><td align="left"/><td align="left"/><td align="left">78.1 (11.6)</td><td align="left">0.6 (10.5)</td><td align="left"/><td align="left"/><td align="left">74.0 (13.3)</td><td align="left"> − 2.8 (11.6)</td><td align="left"/><td align="left"/><td char="." align="char"/></tr></tbody></table><table-wrap-foot><p><sup>a</sup> “ + ” value = score increased (i.e., decreased in oral health–related QoL); “-” value = score decreased (i.e., increased in oral health–related QoL)</p><p><sup>b</sup><italic>p</italic> value were calculated from independent sample <italic>t</italic>-test between IVRO group and SSRO group</p><p><sup>c</sup>Effect size: &lt; 0.2 = minimal change; 0.2–0.49 = small change; 0.5–0.8 = moderate change; &gt; 0.8 = large change</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Change of SF-36 mean total physical health score (PCS) and mental health score (MCS) over time between IVRO group and SSRO group</p></caption><graphic xlink:href="784_2023_4933_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab5"><label>Table 5</label><caption><p>Comparisons of mean (SD) SF-36 total and domain scores of IVRO group and SSRO group from baseline (<italic>T</italic><sub>0</sub>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="2">T<sub>1</sub>-T<sub>0</sub></th><th align="left" colspan="2">T<sub>2</sub>-T<sub>0</sub></th><th align="left" colspan="2">T<sub>3</sub>-T<sub>0</sub></th><th align="left" colspan="2">T<sub>4</sub>-T<sub>0</sub></th><th align="left" colspan="2">T<sub>5</sub>-T<sub>0</sub></th><th align="left" colspan="2">T<sub>6</sub>-T<sub>0</sub></th></tr><tr><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup><break/>(SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic>-value<sup>b</sup></th><th align="left">Mean<sup>a</sup> (SD)</th><th align="left"><italic>p</italic>-value<sup>b</sup></th></tr></thead><tbody><tr><td align="left" colspan="13">Physical health score (PCS) [0–100]</td></tr><tr><td align="left">  IVRO</td><td align="left"> − 15.7 (10.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 8.8 (8.3)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.3 (6.3)</td><td align="left">0.161</td><td align="left"> − 1.6 (6.6)</td><td align="left">0.113</td><td align="left">-0.1 (4.2)</td><td align="left">0.911</td><td align="left">0.1 (5.2)</td><td align="left">0.921</td></tr><tr><td align="left">  SSRO</td><td align="left"> − 16.3 (8.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 6.9 (7.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 2.0 (5.2)</td><td align="left">0.013</td><td align="left"> − 1.1 (5.9)</td><td align="left">0.257</td><td align="left">0.3 (4.7)</td><td align="left">0.687</td><td align="left">1.5 (4.1)</td><td align="left">0.035</td></tr><tr><td align="left">  All</td><td align="left"> − 16.0 (10.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 7.8 (7.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.7 (5.8)</td><td align="left">0.007</td><td align="left"> − 1.3 (6.2)</td><td align="left">0.050</td><td align="left">0.1 (4.5)</td><td align="left">0.820</td><td align="left">0.8 (4.7)</td><td align="left">0.168</td></tr><tr><td align="left" colspan="13">Mental health score (MCS) [0–100]</td></tr><tr><td align="left">  IVRO</td><td align="left"> − 3.7 (9.5)</td><td align="left">0.013</td><td align="left"> − 6.7 (10.5)</td><td align="left"> &lt; 0.001</td><td align="left">0.7 (10.2)</td><td align="left">0.668</td><td align="left">2.0 (6.1)</td><td align="left">0.030</td><td align="left">0.6 (10.6)</td><td align="left">0.722</td><td align="left">2.4 (7.4)</td><td align="left">0.048</td></tr><tr><td align="left">  SSRO</td><td align="left"> − 7.5 (10.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 4.5 (9.3)</td><td align="left">0.002</td><td align="left"> − 1.1 (9.1)</td><td align="left">0.400</td><td align="left"> − 0.8 (7.4)</td><td align="left">0.487</td><td align="left">-0.1 (7.1)</td><td align="left">0.935</td><td align="left">-0.2 (6.6)</td><td align="left">0.853</td></tr><tr><td align="left">  All</td><td align="left"> − 5.5 (10.3)</td><td align="left"> &lt; 0.001</td><td align="left"> − 5.6 (9.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 0.2 (9.6)</td><td align="left">0.808</td><td align="left">0.7 (6.9)</td><td align="left">0.347</td><td align="left">0.2 (9.0)</td><td align="left">0.799</td><td align="left">1.2 (7.1)</td><td align="left">0.161</td></tr><tr><td align="left" colspan="13">Physical functioning (PF)</td></tr><tr><td align="left">  IVRO</td><td align="left"> − 17.9 (18.5)</td><td align="left"> &lt; 0.001</td><td align="left"> − 9.9 (13.2)</td><td align="left"> &lt; 0.001</td><td align="left"> − 0.8 (5.0)</td><td align="left">0.302</td><td align="left"> − 2.7 (13.4)</td><td align="left">0.180</td><td align="left">1.0 (4.5)</td><td align="left">0.141</td><td align="left">0.2 (5.2)</td><td align="left">0.767</td></tr><tr><td align="left"> SSRO</td><td align="left"> − 20.2 (14.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 6.7 (7.8)</td><td align="left"> &lt; 0.001</td><td align="left"> − 3.0 (5.8)</td><td align="left">0.001</td><td align="left"> − 1.8 (7.6)</td><td align="left">0.129</td><td align="left">0.3 (4.8)</td><td align="left">0.637</td><td align="left">1.5 (3.9)</td><td align="left">0.026</td></tr><tr><td align="left"> All</td><td align="left"> − 19.0 (16.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 8.3 (10.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.9 (5.5)</td><td align="left">0.002</td><td align="left"> − 2.3 (11.0)</td><td align="left">0.056</td><td align="left">0.7 (4.6)</td><td align="left">0.170</td><td align="left">0.8 (4.7)</td><td align="left">0.118</td></tr><tr><td align="left" colspan="13">Role-physical (RP)</td></tr><tr><td align="left"> IVRO</td><td align="left"> − 57.6 (40.4)</td><td align="left"> &lt; 0.001</td><td align="left"> − 51.7 (41.2)</td><td align="left"> &lt; 0.001</td><td align="left"> − 7.8 (30.5)</td><td align="left">0.095</td><td align="left"> − 2.1 (13.6)</td><td align="left">0.290</td><td align="left">-0.6 (20.5)</td><td align="left">0.855</td><td align="left">1.8 (14.1)</td><td align="left">0.412</td></tr><tr><td align="left"> SSRO</td><td align="left"> − 65.2 (37.9)</td><td align="left"> &lt; 0.001</td><td align="left"> − 38.1 (40.2)</td><td align="left"> &lt; 0.001</td><td align="left"> − 6.1 (28.3)</td><td align="left">0.154</td><td align="left">1.2 (14.7)</td><td align="left">0.599</td><td align="left">1.7 (15.8)</td><td align="left">0.473</td><td align="left">5.6 (12.1)</td><td align="left">0.009</td></tr><tr><td align="left"> All</td><td align="left"> − 61.2 (39.2)</td><td align="left"> &lt; 0.001</td><td align="left"> − 44.9 (41.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 6.9 (29.3)</td><td align="left">0.027</td><td align="left"> − 0.6 (14.2)</td><td align="left">0.708</td><td align="left">0.6 (18.3)</td><td align="left">0.770</td><td align="left">3.6 (13.3)</td><td align="left">0.021</td></tr><tr><td align="left" colspan="13">Bodily pain (BP)</td></tr><tr><td align="left"> IVRO</td><td align="left"> − 27.9 (23.4)</td><td align="left"> &lt; 0.001</td><td align="left"> − 14.6 (21.2)</td><td align="left"> &lt; 0.001</td><td align="left"> − 1.4 (15.5)</td><td align="left">0.548</td><td align="left">0.3 (21.7)</td><td align="left">0.936</td><td align="left">-1.7 (17.8)</td><td align="left">0.529</td><td align="left">2.2 (17.0)</td><td align="left">0.407</td></tr><tr><td align="left"> SSRO</td><td align="left"> − 32.9 (15.7)</td><td align="left"> &lt; 0.001</td><td align="left"> − 15.7 (21.2)</td><td align="left"> &lt; 0.001</td><td align="left"> − 5.7 (16.7)</td><td align="left">0.027</td><td align="left"> − 4.6 (18.3)</td><td align="left">0.115</td><td align="left">1.2 (20.0)</td><td align="left">0.694</td><td align="left">0.2 (16.0)</td><td align="left">0.926</td></tr><tr><td align="left"> All</td><td align="left"> − 30.3 (23.1)</td><td align="left"> &lt; 0.001</td><td align="left"> − 15.1 (21.1)</td><td align="left"> &lt; 0.001</td><td align="left"> − 3.6 (16.2)</td><td align="left">0.040</td><td align="left"> − 2.0 (20.2)</td><td align="left">0.354</td><td align="left">-0.3 (18.9)</td><td align="left">0.896</td><td align="left">1.3 (16.5)</td><td align="left">0.491</td></tr><tr><td align="left" colspan="13">General health (GH)</td></tr><tr><td align="left"> IVRO</td><td align="left"> − 5.9 (14.6)</td><td align="left">0.009</td><td align="left"> − 4.2 (13.1)</td><td align="left">0.039</td><td align="left"> − 0.1 (17.2)</td><td align="left">0.959</td><td align="left"> − 0.6 (12.8)</td><td align="left">0.743</td><td align="left">1.0 (16.0)</td><td align="left">0.688</td><td align="left">1.2 (15.6)</td><td align="left">0.626</td></tr><tr><td align="left"> SSRO</td><td align="left"> − 3.8 (14.9)</td><td align="left">0.115</td><td align="left"> − 0.6 (11.0)</td><td align="left">0.702</td><td align="left">0.4 (13.7)</td><td align="left">0.845</td><td align="left"> − 0.0 (14.6)</td><td align="left">0.983</td><td align="left">-0.7 (12.4)</td><td align="left">0.695</td><td align="left">2.9 (12.3)</td><td align="left">0.159</td></tr><tr><td align="left"> All</td><td align="left"> − 4.9 (14.7)</td><td align="left">0.003</td><td align="left"> − 2.4 (12.1)</td><td align="left">0.065</td><td align="left">0.1 (15.4)</td><td align="left">0.935</td><td align="left"> − 0.4 (13.6)</td><td align="left">0.809</td><td align="left">0.1 (14.3)</td><td align="left">0.934</td><td align="left">2.0 (14.1)</td><td align="left">0.214</td></tr><tr><td align="left" colspan="13">Vitality (VT)</td></tr><tr><td align="left"> IVRO</td><td align="left"> − 9.1 (17.3)</td><td align="left"> &lt; 0.001</td><td align="left"> − 3.8 (15.7)</td><td align="left">0.121</td><td align="left">1.4 (15.8)</td><td align="left">0.544</td><td align="left">2.8 (12.1)</td><td align="left">0.123</td><td align="left">-0.7 (19.3)</td><td align="left">0.816</td><td align="left">1.4 (15.9)</td><td align="left">0.586</td></tr><tr><td align="left"> SSRO</td><td align="left"> − 15.1 (19.1)</td><td align="left"> &lt; 0.001</td><td align="left"> − 3.3 (16.5)</td><td align="left">0.191</td><td align="left"> − 1.4 (15.4)</td><td align="left">0.531</td><td align="left"> − 1.5 (13.8)</td><td align="left">0.502</td><td align="left">-0.6 (15.2)</td><td align="left">0.803</td><td align="left">0.1 (16.2)</td><td align="left">0.959</td></tr><tr><td align="left"> All</td><td align="left"> − 12.0 (18.3)</td><td align="left"> &lt; 0.001</td><td align="left"> − 3.5 (16.0)</td><td align="left">0.042</td><td align="left"> − 0.0 (15.6)</td><td align="left">1.000</td><td align="left">0.8 (13.0)</td><td align="left">0.568</td><td align="left">-0.6 (17.3)</td><td align="left">0.734</td><td align="left">0.8 (15.9)</td><td align="left">0.667</td></tr><tr><td align="left" colspan="13">Social functioning (SF)</td></tr><tr><td align="left"> IVRO</td><td align="left">-28.9 (26.1)</td><td align="left"> &lt; 0.001</td><td align="left"> − 31.0 (22.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 3.1 (19.1)</td><td align="left">0.288</td><td align="left">1.9 (12.5)</td><td align="left">0.312</td><td align="left">1.4 (18.5)</td><td align="left">0.614</td><td align="left">4.6 (13.3)</td><td align="left">0.034</td></tr><tr><td align="left"> SSRO</td><td align="left">-37.8 (25.4)</td><td align="left"> &lt; 0.001</td><td align="left"> − 24.7 (18.6)</td><td align="left"> &lt; 0.001</td><td align="left"> − 6.7 (16.8)</td><td align="left">0.011</td><td align="left"> − 5.5 (15.3)</td><td align="left">0.027</td><td align="left">-1.5 (13.4)</td><td align="left">0.482</td><td align="left">-0.0 (9.4)</td><td align="left">1.000</td></tr><tr><td align="left">  All</td><td align="left">-33.1 (26.0)</td><td align="left"> &lt; 0.001</td><td align="left"> − 27.8 (20.5)</td><td align="left"> &lt; 0.001</td><td align="left"> − 4.9 (17.9)</td><td align="left">0.012</td><td align="left"> − 1.6 (14.3)</td><td align="left">0.308</td><td align="left">-0.0 (16.2)</td><td align="left">1.000</td><td align="left">2.4 (11.8)</td><td align="left">0.075</td></tr><tr><td align="left" colspan="13">Role-emotional (RE)</td></tr><tr><td align="left"> IVRO</td><td align="left"> − 8.7 (35.4)</td><td align="left">0.103</td><td align="left"> − 18.9 (47.9)</td><td align="left">0.012</td><td align="left">2.2 (34.4)</td><td align="left">0.667</td><td align="left">5.0 (26.9)</td><td align="left">0.212</td><td align="left">2.3 (34.8)</td><td align="left">0.667</td><td align="left">8.1 (30.5)</td><td align="left">0.096</td></tr><tr><td align="left"> SSRO</td><td align="left"> − 20.3 (45.9)</td><td align="left">0.007</td><td align="left"> − 9.8 (28.4)</td><td align="left">0.026</td><td align="left"> − 5.2 (30.9)</td><td align="left">0.267</td><td align="left"> − 0.0 (18.3)</td><td align="left">1.000</td><td align="left">0.8 (23.6)</td><td align="left">0.830</td><td align="left">1.9 (25.1)</td><td align="left">0.661</td></tr><tr><td align="left"> All</td><td align="left"> − 14.2 (40.9)</td><td align="left">0.002</td><td align="left"> − 14.4 (39.4)</td><td align="left">0.001</td><td align="left"> − 1.5 (32.7)</td><td align="left">0.669</td><td align="left">2.7 (23.3)</td><td align="left">0.288</td><td align="left">1.5 (29.6)</td><td align="left">0.630</td><td align="left">5.2 (28.1)</td><td align="left">0.109</td></tr><tr><td align="left" colspan="13">Mental health (MH)</td></tr><tr><td align="left"> IVRO</td><td align="left">0.9 (15.1)</td><td align="left">0.698</td><td align="left"> − 0.4 (14.6)</td><td align="left">0.869</td><td align="left">2.6 (15.4)</td><td align="left">0.266</td><td align="left">0.9 (13.9)</td><td align="left">0.676</td><td align="left">1.0 (16.9)</td><td align="left">0.696</td><td align="left">2.3 (15.0)</td><td align="left">0.339</td></tr><tr><td align="left"> SSRO</td><td align="left"> − 1.6 (13.5)</td><td align="left">0.463</td><td align="left">1.2 (14.8)</td><td align="left">0.599</td><td align="left">1.0 (15.4)</td><td align="left">0.673</td><td align="left"> − 0.2 (14.1)</td><td align="left">0.930</td><td align="left">1.1 (11.2)</td><td align="left">0.517</td><td align="left">-0.4 (11.1)</td><td align="left">0.812</td></tr><tr><td align="left"> All</td><td align="left"> − 0.3 (14.3)</td><td align="left">0.858</td><td align="left">0.4 (14.6)</td><td align="left">0.793</td><td align="left">1.8 (15.3)</td><td align="left">0.274</td><td align="left">0.4 (13.9)</td><td align="left">0.807</td><td align="left">1.1 (14.3)</td><td align="left">0.491</td><td align="left">1.0 (13.3)</td><td align="left">0.514</td></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="Sec18">
                <title>Group difference in the change of perceived psychological and physical–related QoL (SF-36)</title>
                <p id="Par27">Throughout the treatment process, significant group difference in the change in PCS and MCS total scores were only found from <italic>T</italic><sub>1</sub> to <italic>T</italic><sub>2</sub>. SSRO group had a significantly larger increase in PCS (+ 10.0) compared to IVRO group (+ 6.2) (<italic>p</italic> = 0.032). SSRO group also showed a significantly larger increase in MCS (+ 2.4) compared to IVRO group (− 3.0) (<italic>p</italic> = 0.011). There was no significant group difference from <italic>T</italic><sub>2</sub> onwards (Table <xref rid="Tab4" ref-type="table">4</xref>). A few domain scores of PCS and MCS showed group differences. From <italic>T</italic><sub>1</sub> to <italic>T</italic><sub>2</sub>, SSRO group had a significantly larger increase in domain scores of physical functioning (PF), role-physical (RP), vitality (VT), social functioning (SF), and role-emotional (RE) then IVRO group (<italic>p</italic> &lt; 0.05).</p>
              </sec>
              <sec id="Sec19">
                <title>Effect of age and gender on quality of life</title>
                <p id="Par28">No correlation was found between gender of patients and the mean PCS, MCS, and OHIP-14 scores (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). However, there were significant correlations of age with OHIP scores, with increased age correlated with increased OHIP-14 score at the following time points: <italic>r</italic> = 0.23, <italic>p</italic> = 0.026 at <italic>T</italic><sub>3</sub>; <italic>r</italic> = 0.23, <italic>p</italic> = 0.032 at <italic>T</italic><sub>4</sub>; <italic>r</italic> = 0.26, <italic>p</italic> = 0.013 at <italic>T</italic><sub>5</sub>; and <italic>r</italic> = 0.24, <italic>p</italic> = 0.037 at <italic>T</italic><sub>6</sub> (Fig. <xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Comparison of <bold>a</bold> OHIP-14 and <bold>b</bold> SF-36 mean total score with gender</p></caption><graphic xlink:href="784_2023_4933_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Correlation between <bold>a</bold> OHIP-14 and <bold>b</bold> SF-36 mean total score with age</p></caption><graphic xlink:href="784_2023_4933_Fig4_HTML" id="MO4"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec20">
              <title>Discussion</title>
              <p id="Par29">The present study is the first attempt in the literature to compare the oral, physical, and mental impact on patients suffering from mandibular prognathism with two types of orthognathic surgery—IVRO and SSRO. The results of this study indicate that recovery pathway of oral health-related QoL of IVRO and SSRO group were comparatively alike. Patients in both groups experienced an increase of burden in oral health–related QoL at the immediately postoperative period (i.e., <italic>T</italic><sub>1</sub>), and significantly improved by <italic>T</italic><sub>2</sub>. Improvement became stable from <italic>T</italic><sub>3</sub> onwards. Regarding physical and mental health–related QoL, PCS were declined in both groups from <italic>T</italic><sub>0</sub> to <italic>T</italic><sub>1</sub>, and started to improve from <italic>T</italic><sub>1</sub> onward, except that MCS in IVRO group started to improve only from <italic>T</italic><sub>2</sub> onward meaning that IVRO group had delayed improvement.</p>
              <p id="Par30">As expected, immense reduction in all aspects of QoL (i.e., oral-, mental-, and physical-related QoL) were noted, since surgical complications and discomforts were inevitable [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. The oral health–related QoL (OHIP-14) of patients in the SSRO group began to improve earlier than IVRO group, likely to be attributed to the 6-week post-surgery intermaxillary fixation (IMF) in the IVRO group. As observed from the longitudinal data, the OHIP-14 score of IVRO patients only started to significantly decrease from <italic>T</italic><sub>2</sub>, consistent to the timing of removing the IMF. The oral health–related QoL in both groups continued to improve in a same manner from <italic>T</italic><sub>2</sub> onwards, and returned to the baseline level at <italic>T</italic><sub>3</sub>. The process of oral health recovery to the baseline level took 3 months in this study, which was slightly faster than the 6 months reported by some studies [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Besides, oral health–related QoL at postoperative 6 months was higher as reported by some other groups [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. However, it is difficult to compare and draw conclusion on the strength of evidences, as differences in sample size, age, and type of deformity of patients among studies could yield different results.</p>
              <p id="Par31">In terms of physical and mental health–related QoL (SF-36), both PCS and MCS in two groups decreased significantly at <italic>T</italic><sub>1</sub>, but the reduction of PCS was larger than MCS. This indicated that the burden of physical impact was bigger than psychological impact in both groups in early postoperative period. Improvement in physical and mental health–related QoL of patients in SSRO group appeared in <italic>T</italic><sub>2</sub>. However, only improvement of physical health-related QoL was found among patients in IVRO group. Social functioning, emotion, and mental health specifically affected patients in IVRO group. These findings demonstrated that mental health was continuously affected during the IMF period. Normal social functioning, work, and daily activities were interfered by emotional problems. The feelings of nervousness and depress, meanwhile, appeared most of the time as measured by the SF-36 domain scores. Mental health status in IVRO group improved from <italic>T</italic><sub>2</sub> onwards and returned to the baseline at <italic>T</italic><sub>3</sub>, while physical health status returned to the baseline at <italic>T</italic><sub>5</sub>. The significant reduction in mental health burden from <italic>T</italic><sub>2</sub> onwards could be explained by the removal of IMF among patients in IVRO. Physical and mental health–related QoL being among patients in SSRO group also returned to baseline level in <italic>T</italic><sub>6</sub>. These finding suggesting that IVRO and SSRO could both improve patients’ physical and mental health in the long term.</p>
              <p id="Par32">Similar with the results reported from previous studies [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], no correlation between gender and QoL was found. However, the reliability of this data may be impacted by the disparity between males and females in the recruited sample. When comparing the QoL with age, a significant positive correlation of age with OHIP-14 scores was found from <italic>T</italic><sub>3</sub> to <italic>T</italic><sub>6</sub>, with increased age correlated with increased OHIP-14 scores. This indicated that older adults would experience greater burden in oral health–related QoL.</p>
              <p id="Par33">This study facilitates the comparisons between changes in QoL of patients with mandibular prognathism. To provide a more comprehensive picture in understanding the effect of mandibular prognathism after IVRO and SSRO, both clinical oral examination and self-reported oral and general-related QoL are essential. It is important that patients undergoing orthognathic surgery are advised that the structural and functional changes will not only affect physical health, but also mental health. Importantly, patients need to understand that they will experience and need to endure worsened QoL for a short period of time immediately after the surgery. They need to undergo a careful consideration on whether they are willing to endure this in exchange for a long-term improvement.</p>
              <p id="Par34">IVRO, which requires an extended period of IMF, is not favored in many centers in the world, in particular the Western developed countries. The majority of dentofacial deformities in Asia, especially on the Eastern part like Korea, Japan, Taiwan, and our center in Hong Kong, are mandibular prognathism with asymmetry. Because of proven track record of stability and low morbidity for managing asymmetric mandibular hyperplasia, IVRO is still the treatment of choice in many centers in the region. Our center has used both IVRO and SSRO, and sometimes in combination of the two techniques, as the choice for mandibular ramus osteotomies. The choice of which technique to use was mostly surgeons’ preference. This randomized clinical trial is the first in the literature to compare IVRO and SSRO i relation to the patients’ QoL.</p>
              <p id="Par35">In conclusion, orthognathic surgery contributed to the improvement of QoL in the long term. However, patients may need to bear the consequence of deterioration of QoL in the early postoperative period. Several factors such as tolerance levels of the individual, duration of recovery period, and age of undergoing surgery serve to facilitate clinical decision-making for both dental practitioners and patients. Patients appeared to experience more oral and general health burden at early postoperative period after receiving IVRO, but both IVRO and SSRO had similar QoL levels in the late postoperative period. Lastly, undergoing orthognathic surgery at early ages are advised, as older age of patients appeared to have worse QoL.
</p>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <notes notes-type="data-availability">
              <title>Data Availability</title>
              <p>The data is available upon request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethical approval</title>
                <p id="Par36">Ethic approval was granted by the local institutional review board (HKU/HA HKW IRB UW 15–132).</p>
              </notes>
              <notes id="FPar2">
                <title>Consent to participate</title>
                <p id="Par37">Written informed consent was obtained from all individual participants included in the study.</p>
              </notes>
              <notes id="FPar3">
                <title>Consent to publish</title>
                <p id="Par38">Patients signed informed consent regarding publishing their data and photographs.
</p>
              </notes>
              <notes id="FPar4" notes-type="COI-statement">
                <title>Conflict of interest</title>
                <p id="Par39">The authors declare no conflicts of interest.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>English</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Buschang</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Throckmorton</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Does malocclusion affect masticatory performance?</article-title>
                  <source>Angle Orthod</source>
                  <year>2002</year>
                  <volume>72</volume>
                  <fpage>21</fpage>
                  <lpage>27</lpage>
                  <?supplied-pmid 11843269?>
                  <pub-id pub-id-type="pmid">11843269</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>NC</given-names>
                    </name>
                    <name>
                      <surname>Sandy</surname>
                      <given-names>JR</given-names>
                    </name>
                  </person-group>
                  <article-title>Tooth position and speech—is there a relationship?</article-title>
                  <source>Angle Orthod</source>
                  <year>1999</year>
                  <volume>69</volume>
                  <fpage>306</fpage>
                  <lpage>310</lpage>
                  <?supplied-pmid 10456597?>
                  <pub-id pub-id-type="pmid">10456597</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Phillips</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Griffin</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Bennett</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Perception of facial attractiveness by patients, peers, and professionals</article-title>
                  <source>Int J Adult Orthodon Orthognath Surg</source>
                  <year>1995</year>
                  <volume>10</volume>
                  <fpage>127</fpage>
                  <lpage>135</lpage>
                  <?supplied-pmid 9081998?>
                  <pub-id pub-id-type="pmid">9081998</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jung</surname>
                      <given-names>M-H</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of the effects of malocclusion and orthodontic treatment on self-esteem in an adolescent population</article-title>
                  <source>Am J Orthod Dentofacial Orthop</source>
                  <year>2010</year>
                  <volume>138</volume>
                  <fpage>160</fpage>
                  <lpage>166</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ajodo.2008.08.040</pub-id>
                  <?supplied-pmid 20691357?>
                  <pub-id pub-id-type="pmid">20691357</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Landy</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Sigall</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Beauty is talent: task evaluation as a function of the performerʼs physical attractiveness</article-title>
                  <source>J Pers Soc Psychol</source>
                  <year>1974</year>
                  <volume>29</volume>
                  <fpage>299</fpage>
                  <pub-id pub-id-type="doi">10.1037/h0036018</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arndt</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Travis</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Lefebvre</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Niec</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Munro</surname>
                      <given-names>IR</given-names>
                    </name>
                  </person-group>
                  <article-title>Beauty and the eye of the beholder: social consequences and personal adjustments for facial patients</article-title>
                  <source>Br J Plast Surg</source>
                  <year>1986</year>
                  <volume>39</volume>
                  <fpage>81</fpage>
                  <lpage>84</lpage>
                  <pub-id pub-id-type="doi">10.1016/0007-1226(86)90009-3</pub-id>
                  <?supplied-pmid 3947799?>
                  <pub-id pub-id-type="pmid">3947799</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shaw</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>O’brien</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Richmond</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Brook</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Quality control in orthodontics: risk/benefit considerations</article-title>
                  <source>Br Dent J</source>
                  <year>1991</year>
                  <volume>170</volume>
                  <fpage>33</fpage>
                  <lpage>37</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.bdj.4807399</pub-id>
                  <?supplied-pmid 2001299?>
                  <pub-id pub-id-type="pmid">2001299</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zamboni</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>de Moura</surname>
                      <given-names>FRR</given-names>
                    </name>
                    <name>
                      <surname>Brew</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Rivaldo</surname>
                      <given-names>EG</given-names>
                    </name>
                    <name>
                      <surname>Braz</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Grossmann</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Bavaresco</surname>
                      <given-names>CS</given-names>
                    </name>
                  </person-group>
                  <article-title>Impacts of orthognathic surgery on patient satisfaction, overall quality of life, and oral health-related quality of life: a systematic literature review</article-title>
                  <source>Int J Dentistry</source>
                  <year>2019</year>
                  <volume>2019</volume>
                  <fpage>2864216</fpage>
                  <pub-id pub-id-type="doi">10.1155/2019/2864216</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leung</surname>
                      <given-names>YY</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>NSM</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>DTS</given-names>
                    </name>
                    <name>
                      <surname>Au</surname>
                      <given-names>SW</given-names>
                    </name>
                    <name>
                      <surname>Choi</surname>
                      <given-names>WS</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>Y-x</given-names>
                    </name>
                  </person-group>
                  <article-title>Surgical morbidities of sagittal split ramus osteotomy versus intraoral vertical ramus osteotomy for the correction of mandibular prognathism: a randomized clinical trial</article-title>
                  <source>Int J Oral Maxillofac Surg</source>
                  <year>2021</year>
                  <volume>50</volume>
                  <fpage>933</fpage>
                  <lpage>939</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijom.2020.06.023</pub-id>
                  <?supplied-pmid 33168369?>
                  <pub-id pub-id-type="pmid">33168369</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>DTS</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>NSM</given-names>
                    </name>
                    <name>
                      <surname>Leung</surname>
                      <given-names>YY</given-names>
                    </name>
                  </person-group>
                  <article-title>Postoperative stability of two common ramus osteotomy procedures for the correction of mandibular prognathism: a randomized controlled trial</article-title>
                  <source>J Craniomaxillofac Surg</source>
                  <year>2022</year>
                  <volume>50</volume>
                  <fpage>32</fpage>
                  <lpage>39</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jcms.2021.09.023</pub-id>
                  <?supplied-pmid 34627665?>
                  <pub-id pub-id-type="pmid">34627665</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schulz</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Altman</surname>
                      <given-names>DG</given-names>
                    </name>
                    <name>
                      <surname>Moher</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials</article-title>
                  <source>Ann Intern Med</source>
                  <year>2010</year>
                  <volume>152</volume>
                  <fpage>726</fpage>
                  <lpage>732</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-152-11-201006010-00232</pub-id>
                  <?supplied-pmid 20335313?>
                  <pub-id pub-id-type="pmid">20335313</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alolayan</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Leung</surname>
                      <given-names>YY</given-names>
                    </name>
                  </person-group>
                  <article-title>Resolution of neurosensory deficit after mandibular orthognathic surgery: a prospective longitudinal study</article-title>
                  <source>J Craniomaxillofac Surg</source>
                  <year>2017</year>
                  <volume>45</volume>
                  <fpage>755</fpage>
                  <lpage>761</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jcms.2017.01.032</pub-id>
                  <?supplied-pmid 28318920?>
                  <pub-id pub-id-type="pmid">28318920</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wong</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Lo</surname>
                      <given-names>EC</given-names>
                    </name>
                    <name>
                      <surname>McMillan</surname>
                      <given-names>AS</given-names>
                    </name>
                  </person-group>
                  <article-title>Validation of a Chinese version of the oral health impact profile (OHIP)</article-title>
                  <source>Commu Dent Oral Epidemiol</source>
                  <year>2002</year>
                  <volume>30</volume>
                  <fpage>423</fpage>
                  <lpage>430</lpage>
                  <pub-id pub-id-type="doi">10.1034/j.1600-0528.2002.00013.x</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <mixed-citation publication-type="other">Ware JE, Kosinski M (2001) SF-36 physical &amp; mental health summary scales: a manual for users of version 1. Quality Metric Incorporated, Johnston, USA</mixed-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lam</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Gandek</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Ren</surname>
                      <given-names>XS</given-names>
                    </name>
                    <name>
                      <surname>Chan</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey</article-title>
                  <source>J Clin Epidemiol</source>
                  <year>1998</year>
                  <volume>51</volume>
                  <fpage>1139</fpage>
                  <lpage>1147</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0895-4356(98)00105-X</pub-id>
                  <?supplied-pmid 9817131?>
                  <pub-id pub-id-type="pmid">9817131</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lam</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Eileen</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Gandek</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Fong</surname>
                      <given-names>DY</given-names>
                    </name>
                  </person-group>
                  <article-title>The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population</article-title>
                  <source>J Clin Epidemiol</source>
                  <year>2005</year>
                  <volume>58</volume>
                  <fpage>815</fpage>
                  <lpage>822</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jclinepi.2004.12.008</pub-id>
                  <?supplied-pmid 16018917?>
                  <pub-id pub-id-type="pmid">16018917</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jędrzejewski</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Smektała</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Sporniak-Tutak</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Olszewski</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Preoperative, intraoperative, and postoperative complications in orthognathic surgery: a systematic review</article-title>
                  <source>Clin Oral Investig</source>
                  <year>2015</year>
                  <volume>19</volume>
                  <fpage>969</fpage>
                  <lpage>977</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00784-015-1452-1</pub-id>
                  <?supplied-pmid 25804886?>
                  <pub-id pub-id-type="pmid">25804886</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>McGrath</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Samman</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of orthognathic surgery on quality of life</article-title>
                  <source>J Oral Maxillofac Surg</source>
                  <year>2008</year>
                  <volume>66</volume>
                  <fpage>1194</fpage>
                  <lpage>1199</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joms.2008.01.006</pub-id>
                  <?supplied-pmid 18486784?>
                  <pub-id pub-id-type="pmid">18486784</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Ni</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>The changes of oral health-related quality of life and satisfaction after surgery-first orthognathic approach: a longitudinal prospective study</article-title>
                  <source>Head Face Med</source>
                  <year>2016</year>
                  <volume>12</volume>
                  <fpage>1</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13005-015-0098-1</pub-id>
                  <pub-id pub-id-type="pmid">26729217</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baherimoghaddam</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Tabrizi</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Naseri</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Pouzesh</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Oshagh</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Torkan</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Assessment of the changes in quality of life of patients with class II and III deformities during and after orthodontic–surgical treatment</article-title>
                  <source>Int J Oral Maxillofac Surg</source>
                  <year>2016</year>
                  <volume>45</volume>
                  <fpage>476</fpage>
                  <lpage>485</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijom.2015.10.019</pub-id>
                  <?supplied-pmid 26603194?>
                  <pub-id pub-id-type="pmid">26603194</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rustemeyer</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gregersen</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Quality of life in orthognathic surgery patients: post-surgical improvements in aesthetics and self-confidence</article-title>
                  <source>J Craniomaxillofac Surg</source>
                  <year>2012</year>
                  <volume>40</volume>
                  <fpage>400</fpage>
                  <lpage>404</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jcms.2011.07.009</pub-id>
                  <?supplied-pmid 21865051?>
                  <pub-id pub-id-type="pmid">21865051</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Choi</surname>
                      <given-names>WS</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>McGrath</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Samman</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Change in quality of life after combined orthodontic-surgical treatment of dentofacial deformities</article-title>
                  <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
                  <year>2010</year>
                  <volume>109</volume>
                  <fpage>46</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tripleo.2009.08.019</pub-id>
                  <?supplied-pmid 20123378?>
                  <pub-id pub-id-type="pmid">20123378</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hatch</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rugh</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Keeling</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Tiner</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Bays</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Health-related quality of life following orthognathic surgery</article-title>
                  <source>Int J Adult Orthodon Orthognath Surg</source>
                  <year>1998</year>
                  <volume>13</volume>
                  <fpage>67</fpage>
                  <lpage>77</lpage>
                  <?supplied-pmid 9558537?>
                  <pub-id pub-id-type="pmid">9558537</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
